Medgate Today December 2021

EXHIBITION SPECIAL

DIAGNOSTIC COMPANIES MEDICAL DEVICES IMPACT

DIAGNOSTIC

TOP

MEDGATE TODAY’S SURVEY 2021

HOSPITALS IN INDIA

+

UNDER SPECIAL FEATURE

YOUR STORY

H E A LT H C A R E

News Update | Doctor Speak | Expert Views | Product Line | Industry Watch | Healthcare Management

UPDATE

TOTAL SOLUTIONS FOR CLINICAL DIAGNOSIS Diabetes Coagulation Clinical Chemistry

Critical Care Urinalysis Molecular Immunology

Hematology

Transasia Bio-Medicals offers Made in India products that meet your needs for reliable and affordable IVD solutions. Our portfolio is backed by our sales and application support teams that reach out to over 5000 tier II-IV cities, towns and villages in India.

OUR STRENGTHS 150 CRORE+ Blood tests on Transasia equipment every year

70,000+ Installations across India

LIVING OUR LEGACY 40,000+ Laboratories in India with Transasia products

700+ Sales and applications team, the largest in the Indian IVD Industry

COMMITMENT SERVICE TRUST

ENQUIRE NOW

Transasia House, 8 Chandivali Studio Road, Andheri (E), Mumbai - 400 072.

T: (022) 4030 9000, Fax: (022) 2857 3030 www.erbamannheim.com 7304448818 Stay Connected: responses@transasia.co.in

EDITOR SPEAK

Magazine

THE GLOBAL DIAGNOSTICS MARKET IS PROJECTED TO GROW FROM USD 41.49 BILLION DURING 2022.

The medical device industry is evolving at an accelerated pace, incorporating developments in robotics, materials science, analytics and other technology to produce breakthrough devices that are transforming outcomes for patients. Focus, operational excellence, and a collaborative approach are hallmarks of exceptional leadership, and these executives have demonstrated each of these attributes in advancing the competitiveness of their companies and products. Across Diagnostics, Medical devices,Healthcare IT,surgery, wound care, drug delivery, monitoring, and other areas, this year’s leaders have produced some of the most innovative and pervasive medical device technologies worldwide.

Editor-in-Chief

Md. Afzal Kamal

Feature Editor

Razi Ahsan

Editorial Advisor

Sales Head Sales and Marketing Subscription & Circulation Creative Head Creative Designer

GP Capt. (Dr.) Sanjeev Sood Dr. Sharad Lakhotia Sujoy Gomes Reena Rathi, Nisha F Wilson, SY Ahmed Khan, Ranjit Shirsath Rita Sharma, Suhaib, JD Hitesh Dingankar Heema K All right reserved by all everts are made to ensure that the information published is correct 'Medgate today’ holds no responsibility any unlikely errors that might occur.

Circulation Office:

Published by

Advance Media Group Bldg.No-256/6 Office No-02, Near Pocket 10B, Jasola, (Behind Apollo Hospital)

New Delhi - 110025 Tel: +91 - 11 - 2694 6348, 8448432883

The Global Point of care diagnostics market size was USD 34.49 billion in 2020.The Global impact of covid-19 has been unprecedented and staggering , with diagnostics witnessing a positive demand shock across all regions amid the pandemic. As per Fortune Business Insight survey , the Global market exhibited a stellar growth of 86.9% in 2020.The market is projected to grow from USD 41.49 billion during 2022.

Mumbai Office

Office No.18, 1St Floor, Crystal Plaza, Station Road, Mira Road(E), Mumbai-401107 Tel. 022-28102920

Chennai Office

The demand of quality diagnostics kit is like covid19 rapid test, antibody etc. rapidly increasing because of the prevalence of acute and chronic diseases worldwide.

11, Krishnan, Koil Street 3rd Floor Rotary Lane Chennai - 600001

Printed by

Due to uncertainties regarding the duration and impact of the covid-19 pandemic, the POC diagnostics Industry is estimated to witness a strong upward trend in its growth rate.

4

2021

Volume - XII Issue - XII December 2021

October 2021 w w w. me d g a te to d a y.co m

Email: info@medgatetoday.com medgatetoday@gmail.com Visit us: www.medgatetoday.com

DIXIT PRINTERS, 124, Ground Floor Patparganj, Industrial Area, New Delhi-92

Have an insightful reading.

Your suggestions are most welcome!

E-mail: editor@medgatetoday.com Website: w w w . m e d g a t e t o d a y . c o m

3.6+DR

The Smart Solution in Digital Mobile X-Ray Imaging • 110kHz Ultra High Frequency X-ray for reduced skin dosage • 3.5 kw output X-Ray generator • Stationary anode X-Ray tube with a smaller focal spot 1.5mm² for sharper images • Ergonomically designed with ease of maneuverability & more storage space • Latest generation 14"x17" flat panel detector • DICOM/ PACS connectivity • IP-54 (Ingress protection from dust & liquid)

Series DR-1

Easy, fast and safe to operate…..

• 32 KW High frequency Imported X-Ray Generator • 40 – 125 KV Range, 10 – 400 mA Range • 17”x17” CsI Tethered detector housed in cabinet • Imported LED Collimator (160 lux brightness) • Floor to Ceiling tube Stand with 360 Degree Axis Rotation • Ceiling Free Detector Stand with tilting facility (0° - 90 °)

BPL Digital Radiography Solutions Quality in every situation

ISO 13485:2016 CERTIFIED COMPANY ISO 9001:2015 CERTIFIED COMPANY

BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED

Regd. Office: 11th KM, Bannerghatta Road Arakere, Bangalore - 560076, India.

Toll Free: 1800-4252355 Website: www.bplmedicaltechnologies.com For Enquiries: sales.medical@bpl.in CIN: U33110KA2012PTC067282

A BPL Medical Technologies Initiative

Follow Us on A BPL Medical Technologies Initiative

© 2021 BPL Medical Technologies Private Limited. All rights reserved. BPL Medical Technologies Private Limited reserves the right to make changes in product features, specifications, aesthetics and/or to discontinue the same at any time without notice or obligation

BPL MRAD100 MRAD 3.6 PAD 22:10:2021

IMPACT

DIAGNOSTIC

COVER STORY 16-42

INSIDE

VOLUME - XII ISSUE - XII DECEMBER 2021

News Update 08/ AIR POLLUTION IS THE MOST PREVALENT RISK FACTOR FOR NCDS IN INDIA, REDUCES LIFE EXPECTANCY BY 8 YEARS .......................................

12/ LUNG FIBROSIS IS IRREVERSIBLE, BUT IN COVID PATIENTS, IT IS SEEN REVERSED .......................................

....................................................................

18/ RAPID & REMOTE TESTING NEEDS: WILL POINT OF CARE TESTING (POCT) BE THE NEXT STOP IN DIAGNOSTICS? -DR. RAVI GAUR , ONCQUEST LABORATORIES

Doctor Speak 50/ ADVANCEMENT IN EPILEPSY TREATMENT - DR. S. RAGHAVENDRA .......................................

16/ ATIMELY AND TARGETED DIAGNOSIS HOLDS THE KEY TO DEVELOPING DISEASE PREVENTION PROGRAMS AND PROVIDING OPTIMAL TREATMENT - SURESH VAZIRANI, TRANSASIA

14/ SPUTNIK V SHOWS 80% LONGTERM EFFICACY AGAINST COVID IN SAN MARINO FROM 6TH THROUGH ...

.................................................................... ....................................................................

52/ AIDS THROUGH THE AGES: WHY AWARENESS IS KEY TO CURBING THE WIDESPREAD EPIDEMIC DR. SANKET MANKAD

....................................................................

Pre Event

22/ REINVENTING HEALTHCARE WITH TECHNOLOGY - DINESH CHAUHAN, CORE DIAGNOSTICS 24/ THE INDIAN IVD INDUSTRY THROUGH THE PANDEMIC: FROM INSUFFICIENCY TO ATMANIRBHAR - ABHINAV THAKUR

....................................................................

30/ A LEADING CENTER FOR SPECIALIZED TRATMENT DR. MINNIE BODHANWALA, WADIA HOSPITAL

....................................................................

34/ TOP LEADING HOSPITALS IN INDIA - BOMI BHOTE, RUBY HALL CLINIC

....................................................................

38/ TOP LEADING HOSPITALS IN INDIA - NARAYANA HEALTHCARE

54/ INDIA INTERNATIONAL MEDICAL EQUIPMENT EXPO 2022 - 11-13 DEC 2021, AMTZ CAMPUS, VIZAG 56/ HAEMOCON 2022 – INDIA'S MOST COMPREHENSIVE DIAGNOSTIC SUMMIT, HAEMATOLOGY M E D G AT E T O D AY CONFERENCE, AND AWARDS CEREMONY WILL BE HELD ON 21ST INVITATION JANUARY 2022PARTICIPATE INTONEW DELHI

....................................................................

40/ TOP LEADING HOSPITALS IN INDIA - AMRI HOSPITALS

48/ TRENDS IN RADIOLOGY IN A POST-COVID WORLD - AMIT GANDHI

Interview 26/ ONQUEST LABORATORIES WILL BECOME A PROMINENT PLAYER IN THE HEALTHCARE - DR. RAVINDER DEEP SINGH SETHI 28/ DIGITAL HEALTH IS IMPACTING THE WORLD & THE FUTURE OF HEALTHCARE - DR. HARISH PILLAI

Product Line 28/ TRANSITION FROM ANALOGUE TO DIGITAL IMAGING FOR IMAGE GUIDED SURGERIES - MR. SATYAKI BANERJEE

YOUR STORY

H E A LT H C A R E

YOU JOURNEY

Magazine

www.medgatetoday.com

www.medgatetoday.com

CONNECTING HEALTHCARE DIGITALLY & GLOBALLY MAGAZINE AVAILABLE ON DIGITAL PLATFORM

44

MAGAZINE YOUR STORY ADVERTISEMENTS ADVERTORIALS PRESS RELEASE

ONE GLOBAL ORGANIZATION

UPENDER CHAUHAN Magazine

....................................................................

42/ TOP LEADING HOSPITALS IN INDIA -

46/ SIMPLIFYING SETTING UP OF DENTAL PRACTICES - VIVEK TIWARI

INTRODUCING

INDIA’S TOP & WORLD’S FOREMOST HEALTHCARE MAGAZINE

.......................................

20/ INDIAN IVD INDUSTRY CHAMPIONING THE MEDICAL DEVICES SEGMENT - JATIN MAHAJAN , J. MITRA & CO.

Expert View

.......................................

HOSPITALS +

.......................................

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

TOP

REGISTER YOUR

INTEREST COMMERCIAL DIRECTOR SOUTH ASIA info@medgatetoday.com www.medgatetoday.com

+91-11-26946348

NEWS

UPDATE

AIR POLLUTION IS THE MOST PREVALENT RISK FACTOR FOR NCDS IN INDIA, REDUCES LIFE EX PECTANCY BY 8 YEARS •

India registers 18% of deaths annually due to air pollution while 7 million die annually across the world due to air pollution

•

Air pollution caused a total loss of Rs. 2,60,000 crores to the Indian economy in 2019 while $9000 is spent every second in the world due to air pollution

T

he Associated Chambers of Commerce and Industry of India (ASSOCHAM), the apex trade association of the country, with the objective to create awareness and enhance understanding about the severe impact of rising air pollution on human health and to mitigate its impact through preventive measures and effective actions, organised a webinar on ‘Impact of Air Pollution on Health & Life’.

The webinar was addressed by Prof.

Lallan Prasad, Eminent Columnist, Prolific Writer, Economist and Social Activist, and top doctors which included: Dr. G C Khilnani, Former Head & Professor Department of Pulmonary Medicine & Sleep Disorders AIIMS, New Delhi Chairman, PSRI Institute of Pulmonary Critical Care & Sleep Medicine; Dr. Rajiv Chhabra, Chief Paediatric, Artemis Hospitals, Gurugram.

The discussion was moderated by Dr. Rajesh Kesari, Founder and Director, Total Care Control.

Air pollution is the third most man-made potential catastrophe for the ecosystem as well as the health of all living beings including children, expected women, and elderly people. It is the leading cause of critical non-communicable diseases (NCDs) like cardiovascular diseases (CVDs), respiratory illness, lung cancer, stroke, including disabilities and deaths across the globe. Air pollution was responsible for nearly 14% of

8

December 2021 w w w. m e d g a te to d a y.co m

contribution to disability-adjusted life years (DALYs) due to NCDs in India in 2015. Delving on the impact of air pollution on the economy, Prof. Lallan Prasad, Eminent Columnist, Prolific Writer, Economist and Social Activist commented, “According to WHO report, 7 million deaths happen per year globally due to air pollution and every second $9000 is spent across the world due to air pollution. This problem is more severe in South-Asia where countries like India register 18% of deaths annually due to air pollution which caused a total loss of 2,60,000 crore to the economy in 2019 alone.”

Commenting on the severity of air pollution in India particularly in Delhi, Dr. G C Khilnani, Former Head & Professor Department of Pulmonary Medicine & Sleep Disorders AIIMS, New Delhi Chairman, PSRI Institute of Pulmonary Critical Care & Sleep Medicine said, “Air pollution takes us from wellness to illness reducing life expectancy by almost 8 years. In Delhi, people have got used to this fait accompli where every year they will face breathing problems and other health-related issues due to noxious air during the winter season. Air pollution not only affects our immediate health but also makes us prone to several diseases starting from bronchitis, heart diseases, stroke, coronary artery disease, a variety of cancers, etc. During Covid, the severity of the infection and mortality

rate was found to be extreme in regions where the air pollution is high. My sincere advice will be to vaccinate the elderly for flu and pneumonia, use N95 masks, avoid breathing exercise early in the morning, and use a good quality air purifier to reduce the ill-effect of toxic air on our health.”

Highlighting the impact of air pollution on children, Dr. Rajiv Chhabra, Chief Paediatric, Artemis Hospitals, Gurugram added, “Air pollution is a life sentence for an unborn child. It may lead to low birth rate besides impacting child health by making them predisposed to diseases like asthma. Air pollution can also hamper child development resulting in autism later in life. It is also associated with obesity which is the mother of all diseases. Against this backdrop, it is advisable to vaccinate children for diseases like influenza and pneumonia and take a diet rich in Vitamin C, antioxidants, and Omega fatty acids.”

The panel shed light on the economic impact of air pollution. It discussed how air pollution has hit the economy and productivity due to loss of working pollution and by increasing the government’s healthcare expenditure. It discussed the social cost of air pollution which impacts people’s movement leading to psychological problems due to limited social interaction and alteration in consumption behavior.

UPDATE

NEWS

UPDATE

LUNG FIBROSIS IS IRREVERSIBLE, BUT IN COVID PATIENTS, I T IS SEEN REVERSED: SAYS EX PERT 35% of COPD is due to Cigarette & Tobacco Smoking: Says Expert

C

hronic Obstructive Pulmonary Disease (COPD) is currently the third leading cause of death globally. There are 300 million current cases of COPD in the world. To discuss various aspects of Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD), HEAL Foundation organised a dialogue on ‘COPD and Comorbidities’ in the sixth episode of the weekly health show series – ‘Health4All Online’.

Speaking on Interstitial Lung Disease (ILD), Dr Vivek Nangia, Director & Head, Pulmonology Department, Max Hospital, New Delhi, said, “Once the lungs get scarring (injury in lungs) called fibrosis is found to be irreversible.

However, in the case of COVID patients, we have seen in the last one and a half years that this is a unique kind of fibrosis that is developing in COVID patients in the recovery phase and found to be reversible. Initially, we thought that it might not reverse, but it reversed dramatically. Fibrosis is a kind of Interstitial Lung Disease (ILD). This is a blanket term used for over 100 types of such diseases that could cause damage to the lungs.

Dr Vivek Nangia further said, “35% of COPD is due to cigarette and tobacco smoking while 65% of COPD patients are non-smokers.

Chronic Obstructive Pulmonary Disease (COPD) is common in low-and middle-income countries including India. The leading

Dr. Vivek Nangia

Director & Head Pulmonology Department Max Hospital

Dr. J C Suri

Director Dr. Pulmonology Department Critical Care & Sleep Medicine Fortis Hospital

causes are the emission of noxious stimuli such as Cigarettes and tobacco smoking.”

Speaking on Interstitial Lung Diseases (ILD), Dr J C Suri, Director, Department of Pulmonary, Critical Care & Sleep Medicine, Fortis Hospital, New Delhi, said, “ILD is a group of heterogeneous lung disorders. They are also called Diffuse Parenchymal Lung Disease (DPLD). In the majority of cases, we do not know the causes. In some cases, like people who are working in coal mines show the clear reason, but in most cases, it is idiopathic (which arises spontaneously or for which the cause is unknown).”

Adding further, Dr J C Suri said, “Sleep and COPD have a bidirectional relationship.

Usually, when we sleep, our breathing becomes low compared to when we are awake. But this doesn’t affect healthy people. However, people suffering from COPD, Asthma, and neuromuscular disorders or any chronic respiratory disease of moderate to severe degree get affected.

Because of these diseases, our breathing is compromised, and when we go to sleep, our breathing is further compromised. It can

10 December 2021 w w w. m e d g a te to d a y.co m

Mohd Sadiq Azam Cardiologist KIMS Hospital

also result in respiratory failure.”

He also added, “Patients with COPD are at higher risk of cancer because the factors that cause COPD and cancer are common. When the patients are exposed to biomass fuels and occupational pollutants, the chances of developing cancer increase as cancer takes a long time to develop.”

Speaking on the effects of pollutants like particulate matter, the diseases caused due to it and the relationship between lung and heart, Dr Mohammed Sadiq Azam, Cardiologist, KIMS Hospital, Hyderabad said, “Heart and lung are like brothers as they affect each other if not working properly. The Acute cor pulmonale is a form of acute right heart failure produced by a sudden increase in resistance to blood flow in the pulmonary circulation, now rapidly recognized by bedside echocardiography, is caused by lung disease. If we can treat lung diseases, Acute cor pulmonale can be reversed.”

ADVANCED

IMAGING TECHNOLOGY

FOR IMPROVED

SURGICAL OUTCOMES FLAT PANEL DIGITAL C-ARM

High Frequency C-Arm Advanced Flat Panel Detector Digital Subtraction Angiography

Reach us at +91 98400 80008

for more details www.trivitron.com | corporate@trivitron.com

NEWS

UPDATE

AMPATH LAUNCHES I TS PATHOLOGY LABORATORY IN MUMBAI AMPATH offers a wide range of bestin-class diagnostic services with over 2450 tests from Clinical Biochemistry, Hematology, Clinical Pathology, Microbiology, Immuno Phenotyping, Serology, Immunology, Histopathology, Cytology, Immunohistochemistry, Molecular diagnosis, NGS, Cytogenesis and much more. These services help in diagnosis and detection of various diseases affecting different organs and part of the body that can be extremely vital.

The lab has collaborated with UPMC, one of the top ranked hospitals in the United States, which allows them to work with the world’s leading clinicians to help them ensure customers comprehensive services that reflect precision and accuracy in every test conducted. AMPATH is the only Indian lab that has the sole privilege of collaborating with such an esteemed and acclaimed global medical organization.

It has seamlessly managed to keep par with international standards in testing procedures and quality protocols that have been developed under the expert guidance of UPMC. Dr. Jagprag Singh Gujral, Group CEO, South Asia, CTSI, commented, ““We are extremely delighted and pleased to announce the launch of our newest lab in Mumbai. Working in tandem with achieving our vision, we are proud to have expanded our presence in one of the leading markets and will now be able to serve the population of Mumbai with its automated and best in class, advanced test profile and quality standards. CTSI, through its network of 16 Cancer Hospitals in South Asia, American Oncology Institute (AOI), Multispecialty-Citizens Specialty Hospital and chain of specialty diagnostic 12 December 2021 w w w. m e d g a te to d a y.co m

laboratories- AMPATH is at the forefront of providing outcome focused healthcare services in South Asia. We strive to provide top-notch services, innovation and quality driven results in all our endeavors."

Dr. Vijay Kumar Vemuri, Group Chief Operating Officer, CTSI, said, “It is with utmost pride that we share the announcement of the launch of our newest lab in Mumbai. In keeping with AMPATH's standards, the lab has automated streamlined processes, qualified and talented clinical experts with access to top-class technological equipment and are relentlessly trained to follow procedures that deliver accuracy in every single test.”

Commenting on the launch, Dr. Mukesh Agrawal, Lab Director, said, “We are elated on opening a new lab and expanding our presence in the city of Mumbai where we will be offering

various diagnostic services inclusive of microbiology and molecular testing.

With high-tech equipment and a team of skilled professionals, we hope to continually and efficiently service our customers with quality and enhanced healthcare services.”

AMPATH striving closer to its mission of providing world class service and accurate diagnosis, has multiple projects underway to aid its expansion across various geographical locations in India.

They aim to meet India’s constantly changing dynamics in the healthcare sector with consistency and efficiency.

Currently, AMPATH has 10 existing Labs, 1700+ clients & two upcoming Labs in India, with approx. 2450 tests and profiles conducted. It delivers a spectrum of advanced diagnostic services emphasizing quality, ethics, innovation, and best-in-class laboratory practices with reliable performance.

NEWS

UPDATE

SPUTNIK V SHOWS 80% LONGTERM EFFICACY AGAINST COVID IN SAN MARINO FROM 6TH THROUGH 8TH MONTH AFTER ADMINISTERING THE SECOND DOSE

T

he Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the realworld data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective against coronavirus infection from 6th to 8th months after administering the second dose.

Efficacy of Sputnik V on 6-8 months is much higher than officially published efficacy of mRNA vaccines. Sputnik team believes that adenoviral vaccines provide for longer efficacy than mRNA vaccines due to longer antibody and T-cell response.

in July demonstrated that the Russian vaccine has a high safety profile in San Marino. In particular, Sputnik V shows high tolerability profile in ≥60 age group with nearly all reported adverse The data is based on the number of events following immunization being COVID infections in San Marino in mild or moderate and lasting less than November 2021. Efficacy was calculated 2 days. based on data obtained from over 18,600 individuals fully vaccinated with Sputnik V pioneered the heterogeneous Sputnik V not less than 5 months before boosting approach (a “vaccine cocktail” using human adenovirus serotype 26 November. as the first component and human The hospitalization rate with COVID adenovirus serotype 5 as the second infection following vaccination with component). This approach was proven Sputnik V in San Marino was only 0.75 to be successful in creating a longer per 1,000 people during the entire mass and more durable immunity against vaccination in the country from February coronavirus. Sputnik team offered to November 2021. This rate is more its booster shot (one-shot Sputnik than 2 times lower than that of any other Light vaccine) to other vaccines to vaccine used in the country. Over 70% lengthen and strengthen their immune of the adult population of San Marino response and took the lead in initiating have been vaccinated with Sputnik V. An partnerships around the world to article published in EClinicalMedicine conduct joint studies on the combination (an open access clinical journal of Sputnik Light with vaccines of other published by The Lancet, one of the producers. world's most respected medical journals) 14 December 2021 w w w. m e d g a te to d a y.co m

STEP-UP EFFORTS TO INCREASE PHYSICAL ACTI VI T Y: WHO

T

he World Health Organization has called upon countries in its SouthEast Asia Region to accelerate action to address insufficient physical activity which is as high as 74% among adolescents, to arrest and reverse the growing epidemic of non-communicable diseases and promote physical and mental well-being. “Physical activity helps prevent non-communicable diseases such as heart disease, stroke, diabetes and some cancers, which continue to be leading killer diseases in the Region and a risk for severe disease and deaths in the ingoing COVID-19 pandemic,” said Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region.

The Regional Director was addressing a virtual meeting of health officials and partners from member countries where the Regional Roadmap for implementation of Global Action Plan for Physical Activity (GAPPA) was launched. The Regional roadmap aims to facilitate context-specific activities to achieve 10% relative reduction of insufficient physical activity by 2025, and 15% improvement in global levels by 2030. Insufficient physical activity is a leading risk factor for noncommunicable diseases globally and in the South-East Asia Region, where NCDs cause around 8.5 million deaths every year, many of them premature. Globally, 23% adults and 81% adolescents aged 11–17 years do not meet WHO recommendations for physical activity. In the WHO South-East Asia Region, physical inactivity among adults is around 15% and 74% among adolescents.

COVER

IMPACT

DIAGNOSTIC

STORY

TIMELY AND TARGETED DIAGNOSIS HOLDS THE KEY TO DEVELOPING DISEASE PREVENTION PROGRAMS AND PROVIDING OPTIMAL TREATMENT

Suresh

Vazirani

Founder Chairman Transasia-Erba International Group of Companies

W

hat are the key leanings in the COVID era?

Diagnostics is the need of the hour - The pandemic has profoundly raised awareness about the true value of diagnostics and its indispensable role in disease prevention, monitoring and management. Today, every person recognizes that timely and targeted diagnosis holds the key to developing disease prevention programs and providing optimal treatment. Advanced diagnostic solutions and strong healthcare systems can enable patients and clinicians to make important decisions earlier and more accurately. This can further help reduce hospitalization, enable targeted treatment strategies and improve chronic patient management. As a country we need to focus more on preventive care, as it is not just better, but also cheaper to prevent, than to cure. And this would

16 December 2021 w w w. m e d g a te to d a y.co m

mean providing free diagnostic tests for each citizen of India, at least once a year.

Collaboration - The pandemic has also shown the importance of collaboration, between the government and industry, between healthcare workers and regulatory authorities. It has led to critical policy transformations that have accelerated the government’s impetus on Making in India. The decision to set up medtech parks, for example, can help build stronger, sustainable healthcare systems and make available low cost testing solutions.

Faster adoption of newer technologies - Technological advancements are driving patient care. Superior diagnostic technologies such as molecular and NexGen Sequencing are witnessing fast-paced growth for infectious diseases. Transasia is already working on developing pointof-care diagnostic tests for other body fluids, like saliva, making it convenient

for end-users. Besides this, Transasia is also working on developing new technologies for other infectious diseases such as HIV, Hepatitis, TB, etc.

Adoption of digital technology - The pandemic has given an impetus to the adoption of digital technology for better clinical outcomes. Latest developments in the fields of Artificial Intelligence (AI) and Machine Learning (ML), are contributing to digitization, moving diagnostics in the direction of full automation.

Telepathology and telemedicine have made it easier for patients to consult Doctors anywhere, at anytime. With the introduction of the Digital Health Records Program the government too has made a positive move towards creating digital health awareness. At Transasia we are continually looking for ways to optimize how we work to improve patient care.

Manufacturing in India for affordable

IMPACT

DIAGNOSTIC

healthcare - The pandemic has led to a strong realization that only ‘Make in India’ can meet the needs for affordable healthcare. At Transasia, we continue to further expand our manufacturing base. During the complete lockdown, we setup our fifth manufacturing facility at AMTZ, Vizag the largest in Asia for COVID-19 testing solutions. And just recently, we rolled out the first batch of Erba EM 200, fully automated clinical chemistry analyzers, from this facility to meet the growing demand for a wide range of biochemistry tests from laboratories across the country.

Reaching out to those in need - 2021 continued to be a challenging year encouraging many corporates to extend their helping hand to patients and frontline workers. In what has been the biggest humanitarian effort in the history of the company, Transasia continues to arrange to provide free of charge BiPAP machines, cell counters, automated biochemistry analyzers, coagulation analyzers, ESR analyzers, urine chemistry analyzers and oxygen concentrators to state governments to aid various COVID-dedicated hospitals all over the country, especially in rural hospitals.

What are the key initiatives and launches in last 2 years?

Right at the start of the pandemic, the R&D teams of TransasiaErba group based in India, USA and UK collaborated to fasttrack the development of COVID testing solutions in order to offer a complete portfolio for COVID-19 testing and monitoring.

The first kit to be introduced was the ErbaLisa COVID-19 IgG ELISA for surveillance and epidemiological studies. This was followed by the launch of the ErbaMDx COVID-19 RT- PCR kit with five times greater sensitivity to detect even low viral load. Further, Transasia has also developed the rapid antigen test kit for COVID-19.

COVER STORY

approved by National Institute of Biologicals(NIB), Pune.

Please address various breakthroughs & outlook of IVD & Diagnostics markets?

As mentioned earlier, the COVID pandemic has brought diagnostics into focus. According to industry reports, the Indian healthcare industry is projected to reach the USD 372 bn mark by 2022, and the diagnostic market alone is anticipated to grow to USD 32 bn by the end of 2022.

Various trends are contributing to this growth. Greater awareness among patients is leading to them being more aware about their health conditions and opting for preventive diagnostics. Patients are better informed about the different methods of testing, and significance of vital parameters such as CRP, D Dimer and Ferritin among others to monitor disease severity. Growing awareness has led to the opening of new avenues. The use of mobile-based health monitoring systems and small hand-held devices is increasing exponentially.

Having said that, large laboratories will still remain relevant for advanced diagnostic tests. Lab automation and total integration is another growing trend. Various disciplines such as serology, biochemistry, hematology and molecular can be brought together on a common platform for increased efficiency.

As diagnostic care advances, new technologies are evolving to enable pathologists to offer high quality care. Digital pathology is one such technology playing an increasingly critical role in patient care. Digital pathology offers innumerable possibilities for the laboratory to further position itself as the epicenter of a healthcare system – and of each patient’s care journey.

Additionally, there has been a growing demand for tests to monitor other critical parameters during COVID-19. Transasia scaled-up the production and availability of test kits for various parameters such as D Dimer, CRP, Ferritin and LDH and the biochemistry, hematology and coagulation analyzers to meet the growing demand. Besides this, Transasia recently introduced ErbaLisa HCV Gen 4 Ag+Ab, India’s first and only indigenously developed 4th generation ELISA assay for detection of Hepatitis C Virus. It is intended for early detection of Hepatitis C infection. With early detection, there is a much higher chance of curing it. Currently majority of pathology labs in India perform HCV testing based on 3rd generation assays that detect antibodies against the infection only. Though this has been the current method, 4th generation assay offers additional advantages that result in early and more accurate detection of the HCV infection.

Transasia also introduced the ErbaQik rapid test kit for four critical infections namely HIV, HBsAg, HCV and Syphilis.

These kits provide results in 20 minutes and have been

Transasia has set-up its fifth manufacturing facility at AMTZ, Vizag, the largest in Asia for COVID-19 testing solutions w w w.medgatetoday.com December 2021

17

COVER

IMPACT

DIAGNOSTIC

STORY

RAPID & REMOTE TESTING NEEDS: WILL POINT OF CARE TESTING (POCT) BE THE NEXT STOP IN DIAGNOSTICS?

T

RANSITION OF TESTING: NEED OF THE HOUR

In years gone by, healthcare was delivered through home visits by doctors. Then we entered an era of hospital care where patients were admitted and treated. Testing happened through centralized laboratories and samples were analyzed using automated systems for making the right diagnosis.

Covid warranted and accelerated home care, necessitating the need for testing inhome setting. Today, early detection and prevention of disease is a central focus in healthcare. Point Of Care (POC ) testing using portable devices, to diagnose and manage many of the communicable and non-communicable diseases quickly & efficiently, is back in focus. It may be worthwhile to develop rapid, point-of-care diagnostic tests that have sensitivity and specificity similar to those of current gold standard techniques in order to facilitate the expansion of testing. Although there are a lot of improvements in the medical facilities in the Indian healthcare system, the use of POC diagnostic devices is still in its nascent phase.

hospitals, urgent care centers, elderly care centers, emergency rooms, or other resource-limited settings. Some tests can even be performed by patients themselves without requiring a trained professional.

By empowering clinicians to make decisions at the "point-of-care", we can make a significant impact on healthcare delivery and address challenges.

MOVING BEYOND LIMITATIONS

THE

The in-vitro diagnostics market in India is mainly driven by the high prevalence of chronic diseases, the growing use of point-of-care (POC) diagnostics, and the increasing popularity of personalized medicine and companion diagnostics.

Despite the global advancements in laboratory-based clinical diagnostics technologies, developing countries such as India have their own diagnostic challenges, especially in rural and ruralurban settings. The rapid development of portable diagnostic and monitoring devices for POC testing can result in the success of a potential shift from curative, to predictive, personalized, and preventive medicine.

HIGH TIME TO EMPOWER CLINICIANS WITH POCTs

HISTORY: TESTING

The conventional clinical diagnostic procedure requires high-end and costly instruments, an expert technician for operation & result interpretation, and takes longer time, etc. ultimately making it exhausting and expensive. Point-ofcare approaches can provide results at the point of use, such as at home, or in

The POC testing was introduced in 1962 with the development of a method for rapid analysis of blood glucose and shortly after in 1977, rapid pregnancy tests were developed that pioneered a trend of personalized diagnostics. As a result of these developments, POC testing and devices were introduced into

18 December 2021 w w w. m e d g a te to d a y.co m

ORIGIN

OF

POC

clinical settings and laboratories around the world, which changed the diagnostics field greatly. As a preliminary step in clinical diagnosis, POC diagnostics are nowadays widely used and available for a wide variety of analytes, thus reducing the burden on the advanced medical ecosystem. They have not only enhanced the diagnostic capacity for several severe diseases and disorders but also made it affordable for the population in India.

ASSURED CRITERIA World Health Organization (WHO) has laid down ‘ASSURED’ criteria for POC tests in resource-limited settings: •

affordable (by those at risk)

•

sensitive (few false negatives)

•

specific (few false positive)

•

user-friendly (simple to perform and needs minimum training)

•

rapid (producing results within few minutes) and robust (rigid storage conditions)

•

equipment free (no complex system)

There is potential for POC devices to be used by the Indian medical system if they fulfill the above criteria.

FUTURE OF DIAGNOSTICS:

THE

POC

In developing countries like India, there is a huge market potential for POC diagnostic device industries to grow and fulfill the healthcare needs of the vast

COVER

IMPACT

DIAGNOSTIC

STORY

population. According to an industry report, the global market for POC diagnostics is expected to grow at a compound annual growth rate (CAGR) of 11.9% between 2018 and 2023. Many of the POC devices and kits require proper maintenance and need to be operated at a specific temperature. It may not be possible to maintain such conditions in remote places. The sensitivity of a few POC devices and tests may be uncertain at times.

However, in spite of numerous challenges and barriers, the awareness about its benefits is increasing, and gradually, the healthcare system is adapting them too fast.

Innovative POC diagnostic devices are being developed with simple to complex systems, and some devices are being designed with multiplex capabilities. Most of these devices function on principles and mechanisms that include colorimetry, potentiometry, fluorimetry, electrochemistry, paper-based diagnostics, and microfluidics. Lab-on-a-chip technology (which can perform multi-tasking), sensitive biosensors and nanotechnology has revolutionized POC testing. Scientists are developing new techniques that could lead to highly specific, sensitive, and durable pointof-care diagnostic tools.

The future of POC testing lies in the personalization of medicine. Today, wireless technology, the Internet of Things (IoT), and big data not only allows the patient to take more control of their own healthcare, but will also improve the way information is transmitted and interpreted, making healthcare delivery more efficient, precise and ultimately, more affordable.

A CLARION CALL FOR THE INDIAN HEALTHCARE INDUSTRY The Indian healthcare system urgently needs disruptive affordable, accessible, and efficient solutions to address the current challenges. As digitally connected point-of-care diagnostics become more data-centric, they can benefit the primary healthcare system and help India achieve universal health coverage.

Dr. Ravi Gaur

Principal Advisor Spice Health, Founder DrG Path labs Delhi, Co-Convener of CII Health & Wellness Committee Delhi, Ex-Director on Board & Chair Medical Advisory Committee, Oncquest laboratories

w w w.medgatetoday.com December 2021

19

COVER STORY

INDIAN IVD INDUSTRY CHAMPIONING THE MEDICAL DEVICES SEGMENT

Jatin

Mahajan

Managing Director J. Mitra & Co.

20 December 2021 w w w. m e d g a te to d a y.co m

IMPACT

DIAGNOSTIC

COVER

IMPACT

T

DIAGNOSTIC

he Indian In-vitro Diagnostics industry has finally emerged from the shadows. During the corona pandemic, IVD became the principal weapon against the Covid-19 infection. The pandemic has brought the neglected diagnostics segment right into the forefront of the Healthcare industry.

The Indian IVD market was estimated at USD 1240 million in 2019 and may record a CAGR of 7.5% to reach USD 2060 million by 2027.

The Indian IVD industry has been quick to rise to the occasion during the corona pandemic. It quickly developed tests based on different technologies – Antibody tests, Antigen Tests, RT-PCR tests, amongst others. These locally manufactured test kits did an absolute yeoman service when there was a real scarcity of test kits in the market. India was finding it challenging to attain the testing momentum critical to counter the threat of Covid-19. The Indian test kit manufacturers, driven by their extensive R&D, were quick to develop highly potent test solutions across various technologies. This fast and effective action of the Indian diagnostics manufacturers slowed the spread of the coronavirus in India. The large-scale point-of-care (POC) COVID-19 testing itself added USD 9,000 million to the IVD market's value, mostly from RTPCR testing.

India's IVD story is a remarkable example of leadership and planning at various diagnostics and policy ecosystem levels.

The Government and IVD corporates came together to tackle the pandemic effectively. The Government of India, through its flagship "Aatmanirbhar Bharat" initiative, encouraged Indian Medical Devices and IVD manufacturers to meet the ever-increasing demand for essential diagnostics, including Covid-19 test kits and secondary biomarker tests like D-dimer, Ferritin, CRP and IVD Analysers etc India holds tremendous potential in the

STORY

IVD segment and a significant sway in the global diagnostics industry. India is the international centre for frugal medical devices engineering, and India is also among the leading exporters of IVD solutions across the world. The opportunities, therefore, in this segment are tremendous.

The focus of the Indian IVD companies has been on creating an innovationdriven ecosystem for resource-poor settings. The industry strives to develop tests and analyser platforms to address the need for precision and reliability, domestic production (self-reliant), affordability, and reaching closer to point-of-care.

The factors that are catalysing the growth of the Indian IVD market are – an increase of chronic diseases, focus on point-of-care (POC) diagnostics by consumers themselves.

Another growth area within IVD is molecular diagnostics, e.g., RT PCR Test for Covid. Bacterial and viral epidemics, demand for POCD, and evolving technology. All these will further drive growth for the IVD industry in India, and consumers will gain from indigenous availability and increased competition.

The current Indian IVD Market is becoming significantly robust and has tremendous potential, not just for the domestic requirement but also for the international market. Covid-19 has provided the right opportunities and incentives like the PLI Scheme and the evolving environment like Med Tech Parks Schemes for the IVD industry to showcase its true might.

The Government's PLI scheme for the medical devices manufacturing sector will boost domestic manufacturing output, improve the cost competitiveness of Indian devices in the global market, and reduce import bills.

The Future Outlook Embracing technology will enable the IVD players to meet the country's

future needs. Diagnostic services will become more personalised because of Genomics and Genetic testing.

Technological advancements and related investments in a digital delivery platform for IVD tests will bridge the distance divide and bring the industry closer to clinicians and patients worldwide.

An encouraging regulatory ecosystem with the right incentives in place will see this space growing at a rapid pace with faster technology adaptation leading to cost reduction and lower prices India's demand for IVDs will grow further with time because of higher disposable income, better access to quality insurance, POC diagnostics, ageing population due to higher life expectancy, increase in lifestyle diseases and most importantly, the growing acceptance of preventive healthcare and monitoring.

As diagnostic laboratories embrace more automation, they will become more time-efficient, reduce batch testing, and thus reduce overall TAT between test and results. Biomarkers integration and availability of biomolecular tools will catalyse new opportunities for the IVD market by creating condition-specific tests. In addition, artificial intelligence and machine learning will make it possible to achieve higher levels of diagnostic precision.

All these are likely to catalyse an incremental growth of the IVD industry in India in the next few years.

Biomarkers integration and availability of biomolecular tools will catalyse new opportunities for the IVD market by creating condition-specific tests. w w w.medgatetoday.com December 2021

21

COVER

IMPACT

DIAGNOSTIC

STORY

REINVENTING HEALTHCARE WITH TECHNOLOGY

Dinesh Chauhan CEO CORE Diagnostics

22 December 2021 w w w. m e d g a te to d a y.co m

Covid-19 has made patients much more aware of the diagnostic industry and also the benefits of diagnostic testing than before.

COVER

IMPACT

I

DIAGNOSTIC

mpact of the pandemic on the healthcare industry

The COVID-19 pandemic was synonymous to the loss of life and the unprecedented challenges it brought along with it to public health, and the general functioning of the world. It’s no news that it caused both economic and social disruption. Millions of people faced an existential threat.

Nearly half of the world’s global workforce were at a risk of losing their livelihoods. According to a report published in the Scientific Reports (Nature Research) journal, an estimated 20,507,518 life years have been lost due to covid-19 so far across 81 countries, including India.

The pandemic also disrupted the healthcare industry which includes our diagnostics sector. Although the diagnostics industry falls under the category of essential services, owing to the indefinite lockdowns posed extreme challenges, patients started queuing for tests and naturally the turnaround time for reports started to take longer, exposing certain weaknesses in our healthcare system but also providing us with a chance to reinvent it. This period called for a need to partner with patients in the process of healthcare and apply the same throughout operations. Changing demands of the system have started presenting tremendous business opportunities for the diagnostics sector through new products and services and calling for a need to replace old methods that are less functional.

Shortcomings of technology pre-covid

healthcare

Before the pandemic, diagnostic testing was primarily used to support medical professionals in diagnosing illness so that the patient could get further assistance. The covid-19 period required the industry to be more efficient in terms of timeliness as well as accuracy attributes considering the emergency nature of the situation.

Along with this, the situation in the country necessitated an accelerated adoption of digital technologies in the diagnostics, life sciences as well as in the healthcare sector.

The importance of technology in providing affordable and efficient healthcare services cannot be understated. Although India had already started its journey towards digitalisation for a couple of years now, this adoption needed to be speedier for faster result. Therefore with the massive second wave, the country was trying to find the most suitable or most accessible healthcare solutions available. There was a greater need for a push to make use of virtual avenues to connect, communicate, and provide essential services to patients.

Evolution of technology during the pandemic Consumer expectations have naturally undergone changes during the covid run but in the case of healthcare, they also changed very rapidly as a result of the aftermath of the covid.

The diagnostics segment has witnessed tremendous changes

STORY

in the last decade. Digital & technological innovations have been driving the industry. Even during the pandemic, the healthcare space saw developments in diagnostics, via detection, management and treatment of ailments.

During the pandemic, the Indian healthcare sector started showing a stronger resilience through efforts being doubled, whether that was through home collections, drive-through testing sites, telemedicine’s, tele-health services and mobile vans for COVID sample collection. Initially for covid-19 testing, there was not enough capacity and limited supplies to collect and process these tests, which resulted in delays.

However, as we progressed lab equipment improved, capacity and supply expanded and the healthcare staff worked tirelessly to provide results, the entire fraternity standing all as one.

The need for technologies that can be implemented at home were made more apparent than ever, such services gained momentum in areas of diagnosing, preventing, treating, and controlling the spread of the disease. The trust on molecular/ genetic testing has also grown manifold, which has resulted in leveraging technologies such as IoT, wearables, monitoring, connected devices, home-testing processes especially with the advent of easy-to-use medical equipment for self-diagnosis like a BP monitor, Sugar, oximeter, etc. AI technologies have also widened and enhanced the role of diagnosis drastically.

Conclusion The rise of the Coronavirus cases gradually caused eminent changes in individuals’ lives in a lot of ways.

Easier and equitable access to application of various kinds of digital infrastructures are now considered to be essential.

The future of the diagnostics industry will be increasingly digital and recognizing the importance of digital technology in the field has become significant. It has already been clearly established that the three requirements in the diagnostics sector or the healthcare sector as a whole are accuracy, timeliness, and affordability. Covid-19 has made patients much more aware of the diagnostic industry and also the benefits of diagnostic testing than before. Such awareness automatically changes the expectations that customers have from the industry. Now as patients become more aware and accepting to changes like home testing, the demand for more progressive technology is made more transparent. Technology has and will always be helpful in addressing emerging needs that arise from such pandemics. However, its proper use also does require careful governance with strong focus on finding the right balance between public health, social needs and the economic recovery. It lastly depends on the diagnostics industry itself to address evolving challenges through the use of technology and be ready to meet new challenges. The healthcare world as we know it is going through a transformation as a result of COVID. w w w.medgatetoday.com December 2021

23

COVER

IMPACT

DIAGNOSTIC

STORY

THE INDIAN IVD INDUSTRY THROUGH THE PANDEMIC: FROM INSUFFICIENCY TO ATMANIRBHAR

T

he reports began to appear, somewhat quietly, in early 2020. But very soon, the alarm began to ring loudly. A virus called SARS-CoV-2 was suddenly dominating the headlines and threatening lives around the world. The Indian IVD Industry quickly realised they had a new mission and a substantial list of vital undertakings. That list included: • Developing new diagnostic tools • Enhancing Capacity to meet the sudden demand of the COVID waves • Joining forces with governments, other business partners and organisations to accelerate progress • Securing employee safety while maintaining business continuity to ensure supplies of tests reached patients in need • Managing supply chains in difficult period of lockdowns Due to the rising number of cases and the measures initiated by the Government of India, it was evident that India would require a large number of diagnostic tests to screen, identify, diagnose, isolate and treat the infected individuals to contain the spread of the infection.

Initially India was dependent of imported kits as there were no approved kits from Indian manufacturers for COIVID -19 diagnosis. However, the Indian Diagnostic industry swiftly rose to the challenge facing the country. Indian diagnostic manufactures came together and worked hard to come up with kits that were more affordable and easily available compared to the imported kits.

The industry could not only meet the

24 December 2021 w w w. m e d g a te to d a y.co m

Abhinav Thakur

Managing Director Accurex Biomedical Pvt. Ltd.

demand of the country but also created surplus capacity for rest of the world.

Today, more than 100 kits from Indian manufacturers representing different technologies (RT-PCR, LAMP, ELISA, Rapid tests) for detection of viral RNA, antigens and antibodies are approved for use and sale in India.

The success story was possible because all the stakeholders united together in this crisis. The Association Of Diagnostics Manufacturers Of India(ADMI), CDSCO, ICMR and various Government

initiatives such as grants, activation of testing centers, regulatory facilitation etc. worked tirelessly in a synergistic manner to make India self-reliant in COIVD – 19 diagnostic kits.

This unity between all stakeholders is a shining example of the capability, resilience and adaptability of the Indian IVD Industry.

This zenith created by the Diagnostics industry has shown us the path to become self-reliant also in other areas of diagnostics in the future.

GMP

AND MANY MORE PRODUCTS ...

Visit: www.easycareglobal.com

INTERVIEW

INTERVIEW

IMPACT

DIAGNOSTIC

UPDATE

ONQUEST LABORATORIES WILL BECOME A PROMINENT PLAYER IN THE HEALTHCARE Dr. Ravinder Deep Singh Sethi

Chief Operating Officer Oncquest Laboratories Ltd.

T

ell us about your journey and the important milestones achieved under your dynamic leadership.

We have acquired Strand life science Erstwhile Quest Diagnostics in July 2020 immediately after coming on board. To increase the footprint of Oncquest Laboratories, we have planned for 18 Laboratories, focusing primarily for the northern and eastern regions.

Almost all the infrastructure in terms of laboratories, and collection centres are on the ground and are gunning for growth. We are acquaint with automation activities to numerous departments like customer-care, logistics management and home visit verticals to support growth.

Onquest Laboratories will become a prominent player in the healthcare category after launching 18 new Laboratories in this financial year.

The journey was very exciting post Covid as there was a need of quality diagnostic players in Tier 1 and Tier 2 towns and a senior brand like Oncquest is filling the gap for people of India.

26 December 2021 w w w. m e d g a te to d a y.co m

What motivated you to start a business like Pathology and started Oncquest Labs?

We have been in this business of pharma and research for quite a long time.

Oncquest was part of Dabur Pharma, and it was separated from Dabur pharma 13 years back since it is a very challenging line and a tech-dependent industry, so we wanted to provide diagnosis with the best human resources and best of the equipment’s available.

Currently, we are having next-generation sequencing (NGS), DD-PCR, RT-PCR, covid capacity of 20,000 samples to test a day, automated histopathology and IHC platform, Auto-Delfia for maternity screening. We have got all top noch platforms to provide consultant best of the diagnostic reports. The aim is to serve the customer with great dignity and ownership and now we are ready to enter in retail diagnostic with our wellness products.

What are the main services offered by Oncquest Labs?

We are present in lab medicine which

includes biochemistry and immunology.

We are into molecular diagnostic, microbiology, surgical, pathology Immunohistochemistry, genomics, histopathology, including organ biopsy and Frozen sections. Above this, they are also into research and development for clinical and molecular testing. We provide our services to the maritime, drug of abuse, companion diagnosis, and we are also helping Pharma companies for their molecule testing and effects of them on the patients.

Please address various breakthroughs and outlook of the Diagnostics and Pathology market.

After Covid-19, it was a challenging time, and everybody is upgrading their services to satisfy the customer's needs and serve society. The area of digital pathology has boomed tremendously. It is a famous, low-cost, and fast avenue of diagnosis and prognosis of cancer and other chronic diseases. The shift toward digitalization of healthcare and the catalyst effect of the COVID-19 pandemic is expected to increase the adoption of digital pathology in primary diagnosis.

INTERVIEW

INTERVIEW DR. HARISH PILLAI

CEO Metro Pacific Hospital Holdings

D

r Harish's exciting career in Healthcare Management?

Am not sure of the adjective 'exciting ' to describe my career; yes the journey from Hyderabad to Dubai to Cairo to Kochi to Bangalore to Manila does sound like having several fascinating pit stops and it truly has been. The principles of hospital management are the same everywhere and in my journey thus far I was very fortunate to climb the ladder from bottom-up starting in 1999 as an Executive Assistant to the MD of Apollo Hospitals to 2021 as the CEO of a Holding company that manages the largest hospital network in the Philippines. What has always been a blessing is the rich treasure trove of lifelong friendships with my staff and peer groups from all these locations even after leaving and moving on to the adventure called life.

28 December 2021 w w w. m e d g a te to d a y.co m

DIGITAL HEALTH IS IMPACTING THE WORLD & THE FUTURE OF HEALTHCARE How do you see Indian Healthcare? Your key learnings during your time with Indian Healthcare?

Indian Healthcare is on the cusp of transformative changes due to change in the attitude of the government and society at large. Covid has put the right spotlight on the deficiencies and solutions; with increased political

INTERVIEW Indian Healthcare is on the cusp of transformative changes due to change in the attitude of the government and society at large DR. HARISH PILLAI

CEO Metro Pacific Hospital Holdings

capital and budget allocations the current inequities in the system will dissipate over time and a minimum assurance of quality along with ease of accessibility and affordability will be the mantra. My key learnings have been : •

Adopt the right strategic plan based on location and market conditions

•

Build a robust ecosystem that nurtures clinical, service and business excellence

•

Invest in a good clinical governance system that encourages evidence-based practise of medicine

•

Disciplined and cost-efficient operations that are detailed and ensure sustainable margins

•

Importance of an open and transparent management style that engages closely with staff

•

Deep and closer engagement with regulatory agencies to have an open dialogue

•

Impactful contributions to the communities in which we are located

•

Leverage technology for ease of access and enhance clinical and service operations

•

Invest in people and create a sustainable culture which is the bedrock of excellence

What factors made you move to Manila? Your role and responsibilities, future plans?

The opportunity in Manila came out of the blue; being an avid history and culture buff, I had always nurtured a desire to also work in South East Asia and it was just the 'Universe' responding to my subconscious prayers. As the CEO of a healthcare holding company that currently has the largest and a growing network of hospitals in the Philippines; it is a transformative opportunity to work alongside my colleagues and raise the bar in clinical and service excellence. We will continue to grow mostly via M&A and at the same time create an integrated health care delivery model that will support the communities we serve.

How digital health is impacting the world & the Future of healthcare?

Each decade has brought in its wake incredible changes that completely alter the face of an entire system; albeit healthcare has been slow off the block, however, the pace at which innovations are being churned out, this decade will mark an inflection point in mankind's short history. I believe it will democratize healthcare and improve the quality of access multifold and bring down the cost of care. It will make the healthcare system less chaotic, more organized and infinitely safer. The melting pot of bioinformatics, machine learning and artificial intelligence will help us detect epidemic and pandemics earlier and conquer it in record time; we will soon find a cure for all cancers. Science fiction will become a reality by combining cutting edge, costeffective and portable diagnostic tools with nanotechnology and genetic repair. The near term challenge will not be the burden of disease but the impact of climate change and access to potable water.

One earth one health - Insight on Global healthcare?

Unlike civil aviation where we have a global standard for safety; One earth one health is still a far cry for the WHO and the pervasive discrimination seen in Covid vaccine distribution has shown our ugly and selfish selves even though we are aware that in a pandemic no one is safe until each one is safe. The governance system of the WHO needs to be redone and the undue influence of nation-states based on the share of monetary contributions needs to be eliminated. Covid 19 has shown us as a highly vulnerable species and we sincerely hope that the hard and bitter lessons on the missteps in managing this pandemic will result in a new world order - One earth one health!

w w w.medgatetoday.com December 2021

29

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

TOP

MEDGATE TODAY’S SURVEY 2021

HOSPITALS IN INDIA

+

The pandemic has brought the world to a standstill but the healthcare sector has worked above all its capacity to meet the urgent needs of the sudden surge.

EXHIBITION SPECIAL Indian Hospitals are growing day per day with advanced infrastructure and quality equipment.

A significant reason for the growth of the healthcare sector is the continuous effort made by the Indian government as well as private sector to provide better healthcare facilities.

Indian Hospitals are equipped with an experienced and qualified staff, professional nurses, doctors, specialists, surgeons, etc. to take care of the patient and their needs.

There are many good hospitals in India But Medgate today is featuring few top hospitals who have done tremendously good job during 2021 .Medgate Today 17-19 DECEMBER 2021, CHENNAI has interviewed key person of these hospitals. Here will discuss some of the top hospitals in India. The hospitals featured here ews Update | Doctor Speak | Expert | Product Line | on Industry Watch | Healthcare is prepared by editorial team ofViews Medgate Today based their infrastructure ,facilitiesManagement ,better workplace environment ,services and customer reviews .

Wadia Hospital Mumbai

Apollo Hospitals New Delhi

Ruby Hall Clinic Pune

MGM Healthcare Chennai

December 2021 2021 wwwww. w.m m eeddggaatetetotoddaay.co y.comm 30 September

Sahyadri Hospital Pune

Max Healthcare New Delhi

NH Hospital Banglore

AMRI Hospital Kolkata

Medanta The Medicity Gurgaon

P.D.Hinduja Hospital Mumbai

+

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

A LEADING CENTER for SPECIALIZED TRATMENT

STORY

DR. MINNIE BODHANWALA CEO, WADIA HOSPITAL

T

he Wadia Hospitals comprise of two dedicated super speciality public hospitals the Bai Jerbai Wadia Hospital for Children (525 Beds) & Nowrosjee Wadia Maternity Hospital (350 Beds). The Hospitals see an influx of more than three lakh patients on an outpatient basis and more than thirty thousand patients on an inpatient basis annually. Both Hospitals serve the underprivileged section of the society for more than nine decades now.

Give us succinct insights on Wadia Hospital operations and care services?

Bai Jerbai Wadia Hospital for Children is India’s first, one of the largest and best known hospitals for Paediatric care in India established in the year 1929 which provides treatments at minimal or free of cost for the needy and underprivileged children of society. A teaching hospital of worldwide repute, this 525bed hospital is propelled by a highly accomplished team of over 100 Paediatrics specialists. In brightly painted wards, surrounded with their favorite cartoon characters, children are treated for a wide spectrum of rare and complex conditions, in an environment that does its best to keep their spirits high. With tender care by the staff and each doctor taking a personal interest in every child’s health and wellbeing, the hospital sees its responsibility as much more than just medical treatment. Besides providing comprehensive clinical care it also offers rehabilitation and family focused methods of promoting a healthy environment for the child, thus striving to prevent childhood diseases.

Nowrosjee Wadia Maternity Hospital specializes in offering affordable Obstetric and Gynaecological services to women across all sections of society, catering to their changing needs through different stages of their lives. The hospital does not limit its services to its patients alone.

It acts as a tertiary level referral center as well as helps Rehabilitate these women

w w w.medgatetoday.com December 2021

31

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

and their families by showing them methods of improving the health and sanitation around their environment and ensuring a healthy life for their whole family. With a dedicated team of over 40 specialists this 305-bed hospital, declared as a national heritage structure, it also has a constant influx of aspiring doctors who train under some of the best specialists in not only the city but also the country.

Also we are: •

A leading center for specialized treatment for rare and complex medical conditions.

•

A prestigious reputation.

•

State of the Art Paediatric Cardiac Center

•

State of the Art Bone Marrow Transplant Center

•

State of the Art Hemat-Oncology Center

•

Designated Research Center Facility

•

155 bedded NICU, One of the Largest NICU in the world

•

Nodal Center for Club Maharashtra State, India

•

The only Zero Day Dialysis Center for Pediatric in Western India

•

Rehabilitation Center for Multiple disabilities and vision impairment

•

Nutritional Rehabilitation Center in association with UNICEF

•

Referral Center for Multi Drug Resident (MDR) Tuberculosis (TB)

•

State of the Art I.V.F (A.R.T) Center, the first in India to achieve QAI accreditation for IVF services

•

Human Milk Bank

•

First Hospital in India to identify the condition of Multisystem Inflammatory Syndrome (PMIS) in COVID-19 positive children.

teaching

hospital

Foot

with

worldwide

of

(ii) How do you see your Hospital as Top Leading Hospital in India?

Our Children’s hospital is the first dedicated Paediatric hospital established in the country and the largest as well. Today the hospital provides more then 30 super specialty services under one roof, we have 3 OTS where complex surgeries like

32 December 2021 w w w. m e d g a te to d a y.co m

cardiac surgery, neurosurgery etc are performed. We proudly host the largest NICU in the world with 155 beds. We also have a nodal center for clubfoot disease in Maharashtra and have established Cath Lab, MRI centre and a Bone Marrow Transplant unit. We are also looking forward to establish an advanced Cancer treatment unit and Liver Transplant centre.

Our Maternity Hospital specializes in offering affordable Obstetrics and Gynaecology services to women across all the sections of the society; the hospital also specializes in providing IVF care at a much-subsidized cost and also has a human milk bank to help the children who are not fortunate enough to get it. The maternity hospital would undergo a major transformation soon starting with structural stability being a nine decade old structure.

Both our Hospitals have Received Accreditation from National Accreditation Board for Hospitals & Healthcare providers towards entire Hospital Accreditation and Nursing Excellence Accreditation The Hospital has been awarded as the "Best Hospital in COVID 19 Support" by CSR Times Awards 2020, Best Hospital in COVID Response by SKOCH Awards 2020 and "The Best Sustainable Hospital

by Confederation of Indian Industry (CII) Healthcare Excellence Award and Star Recognition.

What sets us apart is the social impact that we create. (iii) How did you overcome the challenges as a Top Leading Hospital in Covid-19 times?

The global pandemic of COVID-19 has burdened the entire healthcare sector across the globe. The impact of COVID 19 pandemic on healthcare sector in India is extremely substantial as we are at the forefront of it. The entire healthcare sector is concentrated on prevention, diagnosis, treatment and containment of COVID-19 infection and this is affecting the timely diagnosis and treatment of other chronic diseases.

With the patients facing problem in movement and fear of COVID 19 spreading across hospitals, the health condition of these patients might end up getting more severe, which will in due course increase the overall burden of diseases on our healthcare system. With more focus of public hospitals on the COVID 19 situation, the low socio-economic group patients which are highly dependent of the government set-ups for all their medical requirements are getting impacted the most including the emergency acute conditions, which would in turn influence the quality of life.

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

COVER STORY

We planned tactically with the correct gears and associates, to positively help the society. We adopted strategies like reallocating resources and by embracing new digital modalities for providing healthcare, which continue to adopt even after the crisis is over. (iv) About your Mission & Vision?

The mission and vision is simple, providing quality and affordable healthcare for all. If we will be able to get the basic things right everything else will fall in place.

With so much of increasing complexity in the health needs of our people the field of healthcare management becomes more and more challenging each day. Also what makes this profession more challenging is a multitude of stakeholders and activities that are involved in running a healthcare organization like physicians and nurses, highly trained employees, ensuring various policies and procedures are complied as per norms, managing supplies, equipment’s and keeping pace with constantly evolving healthcare technology etc. Being a people oriented field it is always necessary to maintain that balance between caring and the sustainability of the organization (v) How competitive you are in your Services?

We try to excel in every front and achieve the maximum for our stakeholders and community at large. Our hope comes from the smile of so many children who are born and treated in our hospitals everyday and we strive for the same smile in the upcoming years.

w w w.medgatetoday.com December 2021

33

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

TOP LEADING HOSPITALS IN INDIA

P

lease tell us about your hospital.

Embracing quality improvement, personalised healthcare and high-end technology for over six decades, Ruby Hall Clinic is an 850-bedded multi-speciality tertiary hospital including a 130-bedded hospital at Wanowrie, a 70-bedded hospital at Hinjawadi and 24 peripheral centres across Maharashtra with over 4000 working staff members.

We have won numerous national and international accolades such as the ‘Best Organ Transplant Centre’ by the Govt. of India; ‘Best Medical Tourism Facility. by then-President Smt. Pratibha Patil and a shield from Late Dr. A.P.J. Abdul Kalam for setting up a state-ofthe-art cancer centre. Additionally, we are the first centre in Pune to perform heart transplants. In fact, we are the only hospital in India to have acquired eight NABH and NABL accreditations and certifications in healthcare by the Quality Council of India in addition to global recognition for our high standards of care.

I can proudly say that today, Ruby Hall Clinic delivers services that go way beyond traditional healthcare.

We’ve been doing what we do for over 60 years, and we’ll continue to build on our success for years to come.

How do you see your hospital as Top Leading Hospital in India?

Bomi Bhote Chief Executive Officer Ruby Hall Clinic

34 December 2021 w w w. m e d g a te to d a y.co m

In an industry that is continually evolving, Ruby Hall Clinic has poised itself to be prepared for the changes to the system as they come, particularly as we shift our focus from reactive care to preventive care. We have a history of proactively anticipating these changes and responding to them before the rest of the players. Despite all these changes in the market itself, our patients have always been at the heart of our operations. Our eight NABH and NABL quality accreditations and certifications in medicine are proof of this very notion. As one of the forerunners in being bestowed with such accreditations, our focus on high-quality patient care speaks volumes in itself.

Moreover, our super-specialist doctors have a track record of excellence. Going beyond reputation and word-of-mouth, our tertiary care services are known to have an excellent rate of results. When it comes to investing in the latest technology or even promoting

COVER EXPERT

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY VIEWS

for patients and even team members that needed monitoring.

Eventually, we partnered with central and state authorities to distribute COVID vaccines while ensuring a successful rollout plan. We trained our nurses, managed the centralised IT system that governed the booking of vaccinations and launched a campaign against vaccine hesitancy. We continued to bust myths surrounding the vaccine and provided the most accurate information to employees, patients and the community at large.

Could you talk about Ruby Hall Clinic’s mission and vision?

organ donation in the country, Ruby Hall Clinic has the firstmover advantage further strengthening our position in the healthcare market. Take, for instance, the fact that we’ve been the first to perform pioneering robotic surgeries in the city. Or even the fact that we have a cutting-edge cancer care facility and an all-women managed breast care clinic. Together, we’ve managed to use our expertise to help people be as healthy as they can be. But it’s not just about our expertise. It’s about support, encouragement and care – not only for our patients but also for our employees. It’s because we care, that we do the best we can. And be the best we can be.

How did you overcome the challenges as a Top Leading Hospital in Covid-19 times?

Initially, when COVID-19 struck, we were amongst the first few hospitals that were leading the fight from the front. Since the surge in cases began, we were extremely well prepared.

We designated separate COVID and non-COVID areas within the hospital, created triage areas, anticipated a higher influx of patients, undertook safety measures during surgeries, ensured robust disinfection practices and participated in a programme to make Indian ventilators.

We focussed our efforts on minimising physical contact as much as possible and deployed the strengths of AI (artificial intelligence) for better patient outcomes, actively utilised telemedicine for care, robots for surgery, e-transactions for payments, AI chatbots for patient information, tie-ups with nearby hotels for patient isolation and webinars for staff training. More importantly, we fine-tuned our daily planning strategies and tactics based on the fluid nature of the outbreak while maintaining the highest level of integrity and transparency. We also partnered with hospitality setups in the vicinity to ensure the continuum of care was maintained

Our late founder, Dr. K.B. Grant entrusted us with a unique legacy that continues to pave the path and inspires to strengthen and grow. Enhancing our position as a recognised leader in the country, we have strived to make quality patient care our priority. Blending compassion with the marvel of technology to make a real difference in the lives of our patients has always been our mission. As a socially responsible hospital, we feel a deep sense of pride and commitment to all those who place their trust in our care and our ‘patient comes first’ policy has been a part of this very philosophy.

How competitive are you in your Services?

At Ruby Hall Clinic, we’ve always believed in thinking about tomorrow’s healthcare today. And this, I believe, makes us stand out amongst our competitors. We have begun to expedite our expansion strategy by focusing on the rapidly growing demand for innovative and comprehensive solutions to support the digital transformation of the healthcare ecosystem. We’ve always charted unknown waters and led from the front.

Be it our award-winning RHC mobile app which was amongst the first in the city to even our newly launched Lab App. We have already incorporated a new EMR system, actively use robotics in surgeries, invested in world-class advanced equipment such as the Halcyon and Truebeam Varian for diagnostics in cancer care and have recently ordered a hybrid cath lab amongst others. Our purpose is simple: to build a digitally enabled healthcare ecosystem where we actively collaborate across the continuum of care to improve each patient’s health outcomes.

We’re also constantly innovating while keeping the changing needs of today’s patients in focus. From contemporary ondemand cuisines to bespoke interiors our Signature Suites have redefined luxury healthcare and this rivals even the finest five-star hotels. Keeping in mind patient comfort, we are also among the first few hospitals in the country to have tied up with financial institutions wherein any patient with medical insurance can avail a loan for their hospitalisation costs within a matter of minutes. As we continue to propel forward, Ruby Hall Clinic will constantly innovate, after all, it comes down to what will benefit our patients the most both today and in the years to come. w w w.medgatetoday.com December 2021

35

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

TOP LEADING

HOSPITALS IN INDIA

Dr. Charudutt Apte Chairman & Managing Director Sahyadri Hospitals Pvt. Ltd.

''

E

VENTUALLY, IT WAS THE TRUST OF OUR PATIENTS THAT LED TO A CHAIN OF SPECIALITY HOSPITALS THAT HAVE THE BEST OF INFRASTRUCTURE, TECHNOLOGY, MEDICAL TEAM, PATIENT CARE AND ABOVE ALL, AN EMOTIONAL BOND THAT BINDS US WITH OUR PATIENTS AND THEIR FAMILIES. SAHYADRI IS CERTAINLY A DREAM THAT HAS TRANSFORMED INTO REALITY.

''

About your Hospital Conceptualized by leading neurosurgeon Dr Charudutt Apte, Sahyadri Hospitals from the very first day of its existence has strived to make healthcare available, accessible and accountable to the community at large - keeping the ‘patient’ at the focus.

The idea started with a humble beginning as a small neurosciences unit in 1994 at a rented place. But with encouraging response from the people and medical community, the idea of serving people with various specialties under one roof was born and became a reality in 2004 with it’s first speciality unit at Deccan Gymkhana, Pune. Sahyadri Hospitals has never looked back since. Today, Sahyadri Hospitals is the largest chain 36 December 2021 w w w. m e d g a te to d a y.co m

of hospitals in Maharashtra operating on the philosophy to make quality healthcare Available, Accessible & Accountable.

Sahyadri Hospitals has grown to 8 hospitals, 900 beds, 2000 clinicians, 2600 supporting staff and over 50 Lacs lives touched.

In sync with it's vision to make healthcare accessible, accountable and available for all, Sahyadri Hospitals has always tried to reach out till the last mile. In order to help the underprivileged, Sahyadri Hospitals has been in the forefront by participating in Government Schemes like MJPJAY at Karad , Nashik and Surya Sahyadri Units. It has dedicated its Surya Sahyadri Hospital Unit solely for this purpose, facilitating quality medical care to many needy patients from vulnerable background. Its deep connect with NGOs

and society at large has ensured many sustainable initiatives especially for the underprivileged. Recently a state-of-theart free dialysis center was launched in collaboration with Rotary Club of Pune Central (Rotary Dist.3131) at Surya Sahyadri Hospital which is proving extremely helpful for kidney failure patients. Soon, it would be launching a radiation Center in Pune dedicated to the underprivileged, to ensure continuity of services for Cancer patients.

How do you see your Hospital as Top Leading Hospital in India?

Sahyadri Hospitals has been in forefront in making quality health care services available to all. With 1 Quaternary care, 4 Tertiary care and 3 Secondary healthcare

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

facilities, it truly is the most accessible hospital chain. Each hospital has an excellent critical care infrastructure, with round the clock availability Trained Critical care experts, along with a backup of Tertiary healthcare services. In Pune, our strength lies in our deep rooted network of hospitals in the city. In Pune, we are just 15 minutes away from you. Apart from Pune, the group today has expanded its footprints in Karad, and Nashik in Maharashtra, which is testimony of group’s philosophy to make healthcare easily accessible.

Working on the similar lines, recently Sahyadri Karad Hospital conducted country’s first liver transplant at taluka level to boost the Liver Transplant Facility in small districts of Western Maharashtra.

Sahyadri Hospitals have always believed in providing accountable services which meet high quality standards, by adopting stringent & accredited quality standards.

Sahyadri Hospitals group has seen a phenomenal growth right from it’s inception and this has been possible due to the trust and goodwill it has earned with people at large. Technology and increasing capacities are two of the most important drivers to meet future goals. Over the next one year Sahyadri Hospitals will be focusing on upgrading infrastructure & expanding bed capacities with an addition of more than 250 plus beds. A lot of thrust will be on Digital Transformation to ensure a better patient experience and offer health care at your fingertips.

STORY

How did you overcome the challenges as a Top Leading Hospital in Covid-19 times?

At a time when the medical infrastructure in the state was overwhelmed, Sahyadri Hospitals led from the front during the pandemic. Apart from quickly adapting to the emerging situation, Sahyadri Hospitals was one of the first private organisations to partner with the Government and local authorities on many fronts, from dedicating some of it’s units entirely for Covid patients to partnering with NGOs for setting up and operationalising Covid Care centres.

During the lock down last year when number of cases were going up, Sahyadri Hospitals offered home well packages for asymptomatic covid patients and online consultations. True to it’s core value of being patient centric, Sahyadri Hospitals also offered home collection of lab samples and home delivery of medicines which made things much easier for all those affected.

About your Missions & Visions?

Mission has always been to make healthcare available, accessible, and accountable to the community at large.

The thrust is to deliver compassionate care with top experts, trained manpower working in sync with the best in class infrastructure, technology and facilities.

How competitive you are in your Services?

Right from it’s inception Sahyadri Hospitals Group has been in the forefront of many path breaking initiatives and has many first’s to its credit. These initiatives have now become the strength of the organization.

Some of the highlights are • Pioneers & Leaders in Neurosciences in Western India • India’s leading Bone Marrow Transplant Centre- conducted in more than 800 transplants till date.

• Fastest growing Organ Transplant Centre in Western Indiacomprehensive facilities for Liver, Kidney, Pancreas & Multiorgan Transplants, Heart & Lung Transplants- Conducted 200+ Liver Transplants in just 4 years.

• Center of Excellence in Cardiac Sciences, IVF, Oncology, Orthopaedics • Dedicates one entire Hospital -Surya Sahyadri exclusively for the underprivileged & govt. schemes, a first of its kind initiative by a Private Hospital in the country .

• Youngest Hospital (Sahyadri Super Speciality Hospital Deccan Gymkhana) to receive NABH Accreditation • Awarded Guinness World Record for Maximum Organ Donation Pledges in 8 Hours • Awarded 'Best Hospital in India for Organ Donation' by National Organ & Tissue Transport Organization (NOTTO)

With plans to upgrade the hospital IT systems, so as to ensure seamless movement of information & transform into a paperless hospital, Sahyadri will strive hard to bring advanced medical technologies to provide world-class Health Care, with a Culture of Caring.

A robust, well integrated, excellence seeking healthcare organization; that is what Sahyadri Hospitals group will always be. All of this will contribute to an enhanced experience for the patients.

w w w.medgatetoday.com December 2021

COVER STORY

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

TOP LEADING HOSPITALS

IN INDIA

NARAYANA HEALTHCARE

N

arayana Institute of Cardiac Sciences is a JCI and NABH accredited heart hospital situated in NH Health city Bangalore. This superspeciality flagship cardiac hospital of Narayana Health is one of the largest in the world and is equipped with 16 dedicated Cardiac Operation Theatres and 6 Digital Cath Labs of which one is a Hybrid, capable of performing both interventional cardiac procedures as well as complex heart surgeries.

ICU, the largest in the world.

Narayana Institute of Cardiac Sciences specialises in complex cardiac surgeries & other cardiac procedures such as Pulmonary Endarterectomy for chronic pulmonary embolism, Aneurysm repairs, Electrophysiology, Endovascular interventions for aneurysms and radio frequency ablations, Valve repairs and ROSS procedures, Left Ventricular remodelling / Dor's procedure, device closure for ASD and VSD and Tetralogy of Fallot.

Narayana Institute of Cardiac Sciences performs heart surgeries both on adults & children. This cardiac centre has dedicated critical care beds for post-operative care and performs Cath Lab procedures routinely. It also has 80 bed dedicated paediatric cardiac

Thrombosis Research Institute in the hospital campus is a notable unit for research and has a number of scientists working in collaboration with TRI, London to develop a vaccine to prevent heart attacks.

38 December 2021 w w w. m e d g a te to d a y.co m

NOMINATE NOW LAST DATE TO APPLY

25th Dec’2021

/medgatetoday

REENA RATHI +91-8448432883

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

TOP LEADING HOSPITALS IN INDIA

A

bout AMRI Hospitals

AMRI Hospitals is one of the largest private healthcare service networks in Eastern India, with three multi specialty tertiary hospitals and a state-of-the-art day care centre in Kolkata, along with another multi specialty tertiary hospital at Bhubaneswar, Odisha. With employee strength of more than 5,000 healthcare professionals, the Group takes care of around 4.5 lakh patients annually, conducting over 35,000 successful surgeries. AMRI has an impressive roster of more than 800 doctors, and a welltrained force of nurses & technicians, who work tirelessly across 1,000-plus beds, backed by advanced technologies and latest equipment. The Group is headed towards a path of steady growth, and is all set to add around 700 beds in the near future at its upcoming cancer hospital in Bhubaneswar, and another tertiary hospital project in Kolkata.

How do you see your Hospital as Top Leading Hospital in India?

AMRI Hospitals brings to the table a class of its own, making the healthcare group a major player in keeping Eastern India ahead of the curve. The Group offers a variety of treatment solutions, and has notched up several ‘first time in India’ and ‘first time in Eastern India’ records in terms of using latest technologies and breaking new grounds. From pioneering leadless pacemakers to using mesh & glue for stitch-less orthopaedic surgeries, the Hospital group has been providing value-for-money services, ever since its launch in 1996. Over the last 25 years, AMRI’s hallmark has been a committed team of doctors and caregivers, who take up the challenge of treating the most

40 December 2021 w w w. m e d g a te to d a y.co m

Mr. Rupak Barua Director & Group CEO AMRI Hospitals

complicated cases, besides stepping up to handle Emergency and Critical Care with dedication, expertise and compassion.

The healthcare Group has made immense contributions to the lives of people, not just from Kolkata and the rest of Eastern India, but also from other parts of South Asia and the world.

How did you overcome the challenges as a Top Leading Hospital in Covid-19 times?

Every since its beginning, AMRI Hospitals has recorded exemplary clinical outcome, which has continued to be the Group’s priority even during the COVID-19 pandemic, from its first

appearance in 2020. Even though the pandemic came as a major disruptor, like it has been across India, given the initial lack of knowledge about the virus, we managed to find our foothold soon. We started by making significant changes to our infrastructure and modified our SOPs to meet the needs of the hour.

We set up isolation wards, formulated fresh protocols for treatment, infection control, and sanitisation, ensured the safety and well-being of doctors, nurses, and other staff, so that we could continue functioning normally for our patients.

We became the first private hospital in Eastern India to dedicate a building for COVID patients, and by March 2021,

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

we had four of our seven towers in Kolkata set aside for the purpose. We also tied up with hotels to set up satellite centres, and even turned India’s largest soccer stadium at Salt Lake into a field, besides creating several clinical records by sending back home even the most critical COVID-19 patients.

AMRI Hospitals’ Mission & Vision AMRI Hospitals brings to the table a class of its own, making the healthcare group a major player in keeping Eastern India ahead of the curve. The Group treats more than 4.5 lakh people every year and conducts around 15,000 surgeries annually, providing value-for-money services, backed by advanced equipment and latest technologies. The hallmark of AMRI Hospitals is a committed team of doctors and caregivers, who take up the challenge of treating the most complicated cases, besides stepping up to handle Emergency and Critical Care with dedication, expertise and compassion. Over the last three decades, the healthcare Group has made immense contributions to the lives of people, not just from Kolkata and the rest of Eastern India, but also from other parts of South Asia and the world.

How competitive you are in your services?

The focus of AMRI Hospitals is to provide its patients value-

COVER STORY

for-money treatment and services, supported by world class human resources and latest technologies. Every since its beginning, AMRI has been a market leader in quality healthcare and has been the first healthcare group to introduce several new technologies to not just Eastern India, but across the entire nation. We have conducted pioneering surgeries & procedures, from nano pacemakers to TAVI in cardiac care, use of O-ARM for advanced neuro care, and Renal Denervation Therapy, the latest in hypertension management, among various other such advanced equipment and implants across various specialities.

We also launched the 361o initiative, which takes a holistic approach towards healthcare, and as the name suggests, goes a step beyond by providing value-added services, like virtual home care, telemedicine, cab services to and fro for OPD patients, and home sample collection, among many other features. At AMRI, we continue to look for advanced technologies so that we can provide our patients the best clinical outcome, which gives us an edge over others in the sector. At AMRI Hospitals, we also have a patient welfare cell, which actively works towards providing patients from lower economic backgrounds quality treatment, including complex surgeries and procedures, at free or heavily discounted rates, aided by our partner network of NGOs and the Group’s mother organisation, Emami.

w w w.medgatetoday.com December 2021

41

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

A

vision that first came to Dr. Naresh Trehan, while practising surgery at the NYU Medical Center in the USA. For every 1000 Indian patients he treated there, another 1000 couldn’t even afford to fly down. That’s when he realised that India needed to have an advance multispecialty medical institution of its own. An institution which not only treats, but trains and innovates too, while providing international standards of technology, infrastructure, clinical care, and a fusion of traditional Indian and modern medicine.

All at one-tenth the cost.

That’s how Medanta was born in 2009 and our continuous efforts of staying true to our core mission, under the leadership of Dr. Naresh Trehan has made us the BEST PRIVATE HOSPITAL IN INDIA.

MEDANTA THE MEDICITY

A

t the behest of his father, in 1971, Dr. Reddy left behind a flourishing practice in Boston and returned to India. On his return he found the medical landscape in the country plagued by gaps in infrastructure, delivery and affordability. Things took a turn for the worse when he lost a young patient who just did not have the means to go abroad for treatment. The incident marked a cross road in Dr. Reddy’s life and steeled his determination to get quality healthcare to India. He set the blueprint to build India’s first multi-specialty private sector hospital. Undaunted and unfazed by the obstacles faced, Apollo Hospitals opened its doors in 1983 and ever since nurtured a goal which read as “Our mission is to bring healthcare of international standards within the reach of every individual. We are committed to the achievement and maintenance of excellence in education, research and healthcare for the benefit of humanity”.

APOLLO HOSPITAL

TOP LEADING O

ver the course of nearly two decades, MGM Healthcare’s flagship Mahatma Gandhi Medical College and Research Institute and Sri Balaji Vidyapeeth (Deemed to be University) have stood tall, with the former ranked 23rd among medical institutions in India (NIRF 2018), and the seventh medical college to be accredited

by American Heart Association. These, along with other teaching institutions and tertiary care hospitals, are the foundation upon which MGM Healthcare’s altruistic aspirations and sterling credentials have been built and are the inspiration for the movement to come.

MGM HEALTHCARE 42

COVER

M E D G AT E T O D AY ’ S S U R V E Y 2 0 2 1

HOSPITALS + TOP

STORY

M

ax Healthcare Institute Limited ("Max Healthcare") is one of India’s largest healthcare organizations. We operate 17 healthcare facilities (3400+ beds) across the NCR Delhi, Haryana, Punjab, Uttarakhand and Maharashtra. Almost 85% of our bed capacity is in Metro/Tier 1 cities. Apart from hospitals, Max Healthcare also operates a homecare business and pathology business under brand names Max@Home and Max Labs respectively. Max@Home offers health and wellness services at home while Max Lab provides Pathology Services outside our hospital network.

Max Healthcare is promoted and led by Abhay Soi as its Chairman and Managing director and co- promoted by KKR, the iconic Global Private equity fund.

MAX HEALTHCARE

A

AMRI HOSPITAL

MRI Hospitals Ltd is the premier private healthcare provider of Eastern India, with three super specialty hospitals at Dhakuria, Mukundapur, and Salt Lake, in Kolkata, a state-of-the-art daycare centre on Southern Avenue in Kolkata, and another super specialty hospital at Bhubaneswar, Odisha. The Group takes care of around 4.5 lakh patients annually, conducting more than 15,000 successful surgeries, with a roster of more than 5,000 healthcare professionals.

An impressive roster of more than 600 doctors and a welltrained force of nursing staff work tirelessly across more than 1,000 beds across its four hospitals, backed by advanced technologies and latest equipment to treat people and save lives. With major changes and developments on its plate, the AMRI Group is headed towards a path of steady growth.

HOSPITALS IN INDIA T

he P. D. Hinduja National Hospital and Medical Research Centre is a multi-specialty, tertiary care hospital in Mumbai, India. It was founded by Parmanand Deepchand Hinduja, in collaboration with the Massachusetts General Hospital, the main teaching hospital of Harvard Medical School, Boston.

The hospital is owned and operated by the London-based Hinduja Group through Hinduja Healthcare Limited, which also operates Hinduja Healthcare Surgical at Khar, Mumbai.

Hinduja Hospital is ranked the sixth best hospital in India, third best among the private hospitals in India,[citation needed] best in Western India, best multi-speciality hospital in metros, and the cleanest hospital in Mumbai.

P.D. HINDUJA HOSPITAL w w w.medgatetoday.com December 2021

43

INTRODUCING

YOUR STORY

H E A LT H C A R E

YOU JOURNEY

One Global Organization

T

ell us Ansell.

D AY M A G A Z I N E YOUR STORY ADVERTISEMENTS ADVERTORIALS PRESS RELEASE

REGISTER YOUR INTEREST info@medgatetoday.com

Upender +91-11-26946348 Chauhan www.medgatetoday.com

Commercial Director South Asia

Our global brands Gammex & Encore surgical gloves are recommended by world’s TOP surgeons.

44 December 2021 w w w. m e d g a te to d a y.co m

something

about

Ansell is a leading global provider of protection solutions. We design, develop, and manufacture a wide range of protection solutions that meet our customers' ever-changing needs and demands. Millions of people every day rely on Ansell's innovative products and safety solutions to protect them in the workplace or at home. The same dedication to quality that started over 125 years ago continues today as Ansell has grown to serve 25 global industries in 120 countries in ways that shape and protect our modern world.

How does Ansell plan to expand in India?

Ansell has expanded rapidly since 2017. Ansell India now operates with a dedicated team in Private, Public, Pharmacy, Dental, and e-commerce.

All verticals are showing exponential growth and opportunities. In July 2021, Ansell announced an investment of ~$80m over the next three years to build a new manufacturing facility in Tamil Nadu (India). The facility will have the capability to produce a wide range of products, with an initial focus on surgical and life science gloves for the Indian domestic market and for export. The new manufacturing plant will be designed and built-in line with Indian Green Building Council criteria to minimize water and energy use, maximize renewable energy use, and meet zero liquid discharge. It will set a new benchmark at Ansell for sustainable manufacturing. It will create an important diversification in Ansell's manufacturing footprint and create significant new capacity to supply our industry-leading portfolio of surgical and life science protection solutions to customers globally. The Chief Minister

of Tamil Nadu Thiru M. K. Stalin and the Industry Minister of the State, Thiru Thangam Thennarasu laid the foundation stone for the new Ansell plant. This investment in India demonstrates again our long-term commitment to growing surgical and life sciences businesses and satisfying the needs of our customers. It will produce latex powder-free as well as synthetic gloves to cover the increasing demand for quality surgical gloves in India India under the 'Make in India' initiative (Atmanirbhar Bharat).

Since we are talking about powderfree gloves, how is Ansell working towards promoting & educating the end-users about powder-free gloves?

India still is predominantly a powdered glove market be it surgical or examination gloves. Powder was introduced in gloves to facilitate donning as latex is sticky while donning. The technology has come a long way since then. Moreover, powdered gloves have many hazardous and harmful effects for healthcare professionals and patients alike. Because of that, in 2017 the US Food and Drug Administration (FDA) enforced a ban on powdered gloves. Germany was the first country to ban powdered gloves in 1998, with the US, UK, Japan, Korea, Hong Kong and others shifting to powderfree gloves soon after. Ansell India has always been at the forefront to provide the highest quality and widest portfolio of surgical and examination gloves to meet the needs of hospitals, surgical centers, dental and general healthcare providers around the world.

What are the technologies that go into making Ansell gloves? How does it help in surgical and dental settings?

Ansell has always been a leader in innovation when it comes to hand protection. We are proud of many

firsts, starting with the first commercial production of surgical gloves in the world.

Ansell has always been committed to providing the highest quality and broadest portfolio of surgical and examination gloves to meet the needs of hospitals, surgical centers, dental and general healthcare providers around the world.

Our products feature unique formulations and proprietary technologies such as DERMASHIELD™, ERGOFORM™, ART™, HYDRASOFT™, SENSOPRENE™, SUREFIT™, HYBRID™ and PEARL™ to deliver advanced glove solutions. i.e. ergonomic comfort to reduce hand fatigue, advanced allergy protection and superior barrier protection.

What are the brands that you currently have in the market?

Ansell markets several well-established brands: GAMMEX® surgical gloves are engineered to respond to the evolving user needs of the surgical community.

ENCORE® surgical deliver optimized solutions to provide a high degree of confidence to surgeons, OR nurses and surgical technicians seeking protection with a high level of dexterity, comfort and grip. The MICRO-TOUCH® premium medical examination gloves are scientifically designed to fully equip and comfortably protect medical professionals.

What should a Healthcare Practitioner look for while buying a good quality glove? And why is it important?

When looking for a good quality glove, a person should look at the AQL (Acceptable Quality Level) level; a low values is better as it is an indicator of pinholes in gloves. Ansell offers gloves with patented technologies like HYDRASOFT™ which has an odorless water-based coating applied on the inside of the glove that helps retain moisture and rehydrates the skin to improve the wearers' skin condition and perform at its best. ERGOFORM™ Ergonomic Design

Technology allows for more comfortable gloves that improve performance and ease musculoskeletal stress that could lead to injuries. DERMASHIELD™ helps the HCP in fast and easy damp or dry hand donning whether it is the first don or during intraoperative changes. ART™ Technology is a proprietary process, integrated into the manufacturing line that helps add an extra level of robustness by minimizing possible defects that may later result in pinholes. These technologies help us differentiate and add uncompromised hand protection for HCP and offering high quality glove.

Ansell is preferred by most of the top surgeons/specialty doctors. I would like to know your comments on that.

Our global brands, GAMMEX® & ENCORE® surgical gloves, are recommended by world's top surgeons.

Driven by innovation, our sterile gloves feature unique formulations that protect them and their patient in all surgical settings. GAMMEX® feels like the second skin while performing a procedure and gives them optimum protection. Our SENSOPRENE™ Technology delivers a glove up to 30% thinner so wearers' experience a high degree of sensitivity without compromising on durability and the optimum skin protection needed from allergies and sensitivities caused by latex or chemical accelerators.

Do you plan to expand your portfolio in the coming time?

Since we see a lot of potential in the healthcare segment, we plan to expand our portfolio by introducing GAMMEX Latex AMT glove. It comes with Ansell proprietary Antimicrobial Technology that kills 99.68% (in under 1min) of Hepatitis C virus surrogate HIV-1 strain Mn 8 common infectious bacteria and also protects the wearer from Covid-19 virus.

We plan to introduce Glove-in-Glove, which is a latex, pre-donned double gloving system of two gloves in one, making it easy to double glove in one don for optimum hand protection from viral

penetration. We further plan to extend our portfolio to radiation gloves with GAMMEX® PI Radiation Attenuation, which is a Polyisoprene protective shield that protects hands from scattered radiation exposure during fluoroscopic procedures. To support our expansion in E-commerce platforms and the alternate care portfolio, we plan to launch many Retail and E-Commerce compliant packs which will assist us in reaching new markets, geographies, capture new customers and provide the right hand protection solutions to first-time buyers.

We want to ensure easy access to quality hand protection solutions across Dental, E-commerce and Pharmacies as we see there is good awareness and demand created for quality products.

Do you see any gaps in the industry currently? How do you plan to fill those gaps?

We still see a significant gap in awareness about gloves at all levels, including Healthcare professionals. There is an opportunity to increase awareness on selecting the right hand protection solution and how to differentiate good quality gloves from the lot available. During the COVID-19 pandemic we have seen substandard gloves being pushed in many markets. We continue to educate HCPs about quality and technologies that are important to end-users through training and roadshows. As I shared earlier, a lot of people have been using powdered gloves predominantly even today, even after it being banned in countries like the U.S., U.K., Germany, Japan, and many following soon after due to its harmful effects on HCPs and patients. Looking at the harmful effects we intend to bridge the gap by conducting education programs and shifting the HCPs to powder-free gloves. We continue to invest in more production capacity and capabilities. Our new manufacturing facility will produce surgical gloves and life science products for the Indian market and for export. The facility will be fully integrated with its own compounding, dipping, packaging, Gamma sterilization and warehouse facilities. w w w.medgatetoday.com December 2021

45

EXPERT

VIEWS

SIMPLIFYING SET TING UP OF DENTAL PRACTICES VIVEK TIWARI

CEO, Medikabazaar

A

s the pandemic caught hold of the world, Dentists felt the effects of lockdowns, suspension of routine work, and restricted movement for patients and clinicians alike. During the first wave of the pandemic, routine dental services were restricted due to limited supply of personal protective equipment (PPE), to contribute in flattening the curve, and protect patients and dental personnel against infection.

The inevitable consequence of such conditions was a significant reduction in turnover, affecting cash flow and dental practitioners encountered financial strain. The pandemic caused two major implications on dental practitioners: the dental clinicians’ earnings got affected and even patients were not too keen on seeking treatments.

Patient Unwillingness: As the economic effects of lockdowns started to reflect, along with fears of contracting Covid-19, patients also put dental treatments on the backburner due to financial constraints, choosing to only undertake treatment for serious conditions.

Time Inconveniences for Dentists in Dealing with Multiple Vendors: A dental clinic includes many moving parts like high-tech equipment such as dental chairs, X-ray machines, innumerable consumables, disposables like masks, gloves, syringes and precision instruments like endo motors, handpieces etc. Usually, the same vendor will never have all product types at hand, thus pushing dentists to approach multiple vendors. Therefore, taking away precious time and energy that CHANGES BROUGHT ABOUT BY dentists could devote to treating patients.

THE PANDEMIC Increasing Trend of Dentists Buying The pandemic-induced lockdowns Online: meant that people placed their elective Supply chains and the manufacturing surgeries and dental treatments on the ecosystem suffered due to lockdowns, backburner; thus drying up the inflow as industries witnessed complete of people that needed regular in-facility shutdowns. This in turn affected clinical interventions such as root canals and procurement, which led dentists to move cosmetic treatments. Losses in revenue to buying medical supplies through have been met with a sharp increase in online channels. costs for dental establishments since the Lengthy Documentation for Finance: beginning of the pandemic.

46 December 2021 w w w. m e d g a te to d a y.co m

Financial procedures that can easily be done in one visit, often require multiple visits. Lengthy finance approval processes make setting up a dental clinic more stressful.

HOW MEDIKABAZAAR DENTAL HELPS Medikabazaar, India’s largest online portal for B2B medical supplies and equipment, offers the most comprehensive and largest catalogue for dental products. Our dedicated dental microsite is designed for dentists and dental clinics with an aim to provide an entire gamut of dental solutions under one roof. Under this initiative, Medikabazaar has put together a variety of offerings making the microsite a compelling value proposition vis-avis product range, crowns, financing options, and special offers and discounts.

Dentists can set up their whole dental clinic simply by visiting medikabazaar. com/dental where they can explore India’s widest dental catalogue with over 20,000 products. From procuring authentic dental supplies and product discovery to price comparison between various brands, the platform offers of a plethora of features. It also facilitates the final delivery of the entire range of products needed to set up a dental clinic.

Medikabazaar Dental has offerings tailored for all dental needs, be it for individual practitioners wanting to set up or upgrade their establishment, dental clinics aiming to buy products (on a one-time/recurring basis), or hospitals wanting to procure complete dental supplies.

Besides solving problems of having to deal with multiple vendors, Medikabazaar is also providing financing options to make setting up dental clinics easy and affordable, with the help of our smart and flexible payment offering Medikabazaar Freedom. Dental practitioners can also avail a flat discount on dental products for orders above Rs. 2,499 as part of the special online offer.

EXPERT

VIEWS

TRENDS IN RADIOLOGY IN A POST-COVID WORLD Artificial Intelligence and Deep Learning are playing a major part in designing these systems to enable precise diagnosis.

Amit

Gandhi

Business Leader MRI, CT & AMI

Philips Indian Subcontinent

48 December 2021 w w w. m e d g a te to d a y.co m

T

he increased demand for medical imaging over the last few years, especially because of the pandemic, has resulted in radiology workflows becoming more complex. These developments have necessitated development of new and innovative ways of working that help in enhancing productivity, accuracy and ultimately, outcomes. Further, the pandemic has also created a need to look for ways to provide care remotely whilst ensuring state-of-the-art treatment for patients.

Patients in both metro and non-metro cities have been open to the idea of online consultations and remote care during the pandemic. A recent study titled Rise of Telemedicine – 2020 pointed out that there was a 502% spike in online consultations from people above the age of 50. Additionally, online consultations in cities such as Bengaluru, Delhi-NCR, Mumbai, Pune, Hyderabad, and Kolkata grew by more than 300%.

The new innovations and workflows that emerged during the pandemic are here to stay and will be mutually beneficial to everyone in the health continuum.

Changing times, new approaches Here are a few trends that we witnessed in radiology over the last few years that will shape the new model of healthcare delivery post-COVID-19:

Focus on increasing productivity: In a country like India, where the burden on healthcare institutions is immense, it has become important to use radiology assets more efficiently to ensure optimum outcomes for everyone. The volume of cases in India has necessitated for health-tech companies to focus on providing solutions that can enable radiologists to increase the pace of scans while maintaining the quality of the same. Additionally, healthcare costs are also on the rise in both developed and developing nations, which has further created a need for more efficient healthcare systems. To address these concerns, several health technology companies have developed AI-based solutions to bring down MR scan times dramatically by almost 50%. Artificial Intelligence (AI) brings promising new possibilities to MRI scanning, as it can be applied to many aspects of the overall examination, like automated planning, segmentation, and report creation. Scan acceleration is one of these new possibilities, as AI enables the acquisition of less data during an MRI examination, helping to reduce the time that a patient needs to be in the scanner.

Precision Diagnosis: Workflows that include fragmented systems, complex administrative tasks and those that require workarounds can threaten the precision of diagnosis and weigh heavily on staff and patients. Healthcare providers have many pain points, from appointment no-shows to systems that are not integrated to staffing shortages and increased patient

EXPERT

VIEWS

demands. When one considers the cumulative effect these problems have on the workflow, removing the challenges is critical. COVID-19 exposed inconsistencies in the workflow of healthcare institutions, who are now looking for new solutions that can address these challenges. One such solution which is now available, aims to automate the process of positioning of a patient through camera-based workflow before their scan is conducted. This can help to reduce human errors that could happen during the process and more importantly allow the technicians to remotely operate the CT avoiding contact with the patient. Artificial Intelligence and Deep Learning are playing a major part in designing these systems to enable precise diagnosis. As an example, for CT images, neural networks have enabled healthcare providers to reconstruct images based on low dose at much lesser time, when compared to traditional methods. Such examples are going to become more common in the future as several health-tech companies are working on similar models.

Remote operations: The COVID-19 pandemic was a black swan moment for people in the healthcare space as all elective medical procedures/tests were suspended to focus on treatment of COVID patients. This created a need for healthtech companies to innovate and look for alternatives to in-hospital scans. Therefore, the idea of remote radiology centres has been gaining more traction amongst key stakeholders. Globally, such remote centres have been used by big centres as hub and spoke models to ensure uniformity. In countries such as India, these centres can have great applications as they will address the challenge of a smaller number of radiologists in the country. The power of AI coupled with remote operations will transform the way radiologists approach their jobs as they will now be able to increase the number of cases that they are able to evaluate.

Personalized Diagnosis and Predictive Technology: Today, there is an increasing consensus amongst the healthcare community that different bodies can respond differently to the same course of medicine. Therefore, a personalized healthcare approach is becoming increasingly important. Another key aspect related to precision diagnosis today is the concept of predictive technology. Predictive technology focuses on anticipating diseases that patients might be susceptible to based on their respective medical histories.

These trends reflect how digitization, virtualization and their integration with AI, Neural Networks and Deep Learning can make a real difference to radiology operations especially in a post-COVID world. By connecting data, technology, and people at every defining moment – always with the patient firmly at the center – we can pave a clear path to precision diagnosis and treatment.

w w w.medgatetoday.com December 2021

49

DOCTOR ADVANCEMENT IN EPILEPSY TREATMENT SPEAK

E

pilepsy is a brain disorder characterized by occurrence of recurrent unprovoked seizures. These seizures are due to abnormal electrical activity in the brain manifesting in various forms depending on the area of the brain involved. Epilepsy is associated with psychological and social consequences. In India approximately 10 million people are living with epilepsy.

Appropriate diagnosis and treatment can reduce the frequency of seizure episodes, prevent complications and reduce the risk of sudden unexplained deaths in patients with epilepsy.

Over the last few decades, the management of epilepsy has made tremendous progress in terms of both medical and surgical management.

Epilepsy management needs a multidisciplinary team approach that involves Epileptologists, Neurosurgeons, Neuroradiologists, Electrophysiologists, Psychologist, Psychiatrist and EEG Technologists. There are many specialized comprehensive epilepsy centers that aim to providing the best care with advanced imaging technologies.

DR. S. RAGHAVENDRA Consultant Neurologist and Epileptologist Manipal Hospital

50 December 2021 w w w. m e d g a te to d a y.co m

DOCTOR SPEAK

Newer anti-epileptic drugs

Electroencephalography (EEG):

There are more than 30 drugs available as anti-epileptic agents. Many of the newer drugs have a better safety profile when compared to the older drugs. Targeted therapy is often practiced for treatment of epilepsies related to genetic mutations. Availability of intranasal or buccal formulations of medications with a quick onset of action can also be used in emergency situations for treatment of recurrent seizures, prolonged seizures or status epilepticus.

EEG is one of the most important tests for determining the type of epilepsy and helps in differentiating generalized from focal epilepsy. In cases with focal epilepsy, seizures can be localized from one area of the brain based on the epileptic discharges and electrographic seizure onset. Advanced EEG techniques may be useful in certain patients who can benefit from surgery for further precise localization. In such cases electrodes can be stereotactically placed in the brain either robotically or using a frame. In addition, it facilitates in functional mapping with stimulation studies. RF thermocoagulation can be used in a subset of patients where seizures have a very focal onset.

Technological advances: Advanced techniques:

neuro-imaging

MRI is commonly used for the diagnosis of lesional epilepsy. With the advent and availability of 3T MRI, detection of lesions causing epilepsy has become easier. However, some patients may not show any abnormality on routine MRI. These patients may require advanced imaging techniques such as PET scan, SPECT scan, MEG etc. for better diagnostic imaging.

In addition, functional MRI can help delineate the eloquent cortex and its proximity to the epileptic lesion to anticipate and avoid surgical complications. These advanced imaging techniques are particularly useful in patients requiring surgical management for epilepsy.

Surgical advances: The availability of sonowand and intraoperative MRI has further eased localize the lesion after craniotomy. With newer anesthetic agents, it is now possible to do awake craniotomies and ontable functional mapping specially when operating close to eloquent cortex/ language area. Procedures like Vagus nerve stimulation, responsive neurostimulation and deep brain stimulation are among the newer treatment strategies to control difficult to treat epilepsy

We provide Respiratory Care Products for F Asthma F Sleep Apnea F COPD

GALAXY

F Snoring...etc

WINDOWN

Ikop edIko Med

TM

op kop edIkI Med TM

MedIkop MedIkop

®

Doctor’s Choice

AIRFORCE HANDY 3 BALL SPIROMETER ENDO MASK Meed dIIko kop

ENDO MASK SINGLE DIAL VENTURI WITH NEBULIZER

TM

TM

op dIkop Me MedIk

TM

MedIkop MedIkop

NASAL MASK

BOTTLE

TM

HOSE PIPE

NIV NASAL MASK CPAP NASAL MASK MUCUS EXTRACTOR

For Hospital & Home Care use OUR SUPPLY SECTOR CORPORATE HOSPITAL l MEDICAL INSTITUTIONS GOVERNMENT & BMC TENDERS HOSPITAL & NURSING HOME l EXPORTERS +91 22 26853817 +91 9372605211

MedIkop MedIkop

TM

MedIkop MedIkop

TM

+91 9819065789 +91 9820252232

www.medikoplifescience.in Made in India

infomedikop@gmail.com sales@medikoplifescience.in ISO 9001:2015, ISO 13485:2016,

* Registered Design GMP & CE CERTIFIED COMPANY

w w w.medgatetoday.com December 2021

51

DOCTOR SPEAK

AIDS THROUGH THE AGES: WHY AWARENESS IS KEY TO CURBING THE WIDESPREAD EPIDEMIC

A

IDS is perhaps one of the most widespread epidemics to have plagued mankind, affecting crores of individuals through the ages. According to World Health Organization (WHO), the disease has claimed about 36.3 million lives so far.

6,80,00 people succumbed from the disease in 2020 alone.

AIDS is fatal for adults and children alike and remains one of the most urgent medical crises that continues to affect countless individuals each year. UNICEF, in its latest report identifies that each day in 2020, approximately 850 children became infected with HIV and approximately 330 children died from AIDS related causes.

While AIDS patients can continue to live long and healthy lives through proper healthcare, inadequate access to HIV prevention, care and treatment services are the root cause of mortality amongst patients of all age groups succumbing to the disease.

But AIDs awareness remains a huge challenge for health authorities everywhere, owing to the heavy stigma attached to the disease and the widespread division, disparity, and disregard, which are the key failures when it comes to combating this global health crisis. COVID-19 also continues to make access to timely treatment more challenging for AIDS patients, creating a bigger gap between people suffering from the disease and proper healthcare.

DR. SANKET MANKAD

MD, F.I. D - CMC, Vellore Infectious Diseases & HIV AIDS Consultant Shalby Multispecialty Hospitals 52 December 2021 w w w. m e d g a te to d a y.co m

As a disease that disproportionately attacks low- and middle-income countries, with a majority of sufferers living in Sub-Saharan Africa, the disease needs the urgent attention of authorities who can identify the gaps and develop strategies to build awareness. With the troubling statistics about the disease world over, it is clear that HIV awareness, testing, and prompt

DOCTOR SPEAK

diagnoses continue to lag in low socio-economic areas of the world. In India, populations which are at a higher risk of HIV are female sex workers, men who have sex with men, injecting drug users, and transgenders.

According to UNIAIDs, about 27.4 million people with HIV (73%) were accessing antiretroviral therapy (ART) globally.

This means the other 10.2 million people suffering from the disease are yet to get proper treatment. The pandemic further disrupted the widespread global targets to reduce HIV infections and spread awareness, further derailing prevention and treatment efforts owing to social distancing practices across the globe. Hence the goal of reducing new HIV infections to fewer than 500,000, reducing AIDS-related deaths to fewer than 500,000, and eliminating HIV-related stigma and discrimination by 2020 was not met.

However, HIV treatment has come a long way through the ages. As a disease that continued to spread rapidly in the second half of the 20th century, the epidemic was at its peak in 1997. With time, the world has seen a 52% reduction in new HIV infections. In 1997, 3 million people reported new HIV infections, compared with only 2.1 million in 2010 and 1.5 million in 2020. This is because of the availability of a widening array of effective HIV prevention tools and methods and a massive scale-up of HIV treatment in recent years. The focus of the national programmes will be on achieving the following fast track targets: (i) 75% reduction in new HIV infections, (ii) 90-90-90: 90% of those who are HIV positive in the country know their status, 90% of those who know their status are on treatment and 90% of those who are on treatment experience effective viral load suppression, (iii) Elimination of mother-to-child transmission of HIV and Syphilis, and (iv) Elimination of stigma and discrimination The awareness process for HIV must encompass all the important spectrums to cover when combating the disease,

namely HIV testing, HIV treatment care, HIV Continuum care, and limiting mother to child transmission. HIV testing is one of the most important steps in the process, and extremely important to avoid the transmission of the disease from one person to another. According to UNIAIDS, 84% of the people suffering from the disease knew their HIV status. This is a positive indicator, as testing is the first step towards keeping the virus in check throughout the world. The next step in the process is treatment. As of today, HIV is incurable but can be kept in check through antiretroviral therapy (ART). Patients who take ART daily as prescribed and get and keep an undetectable viral load can live long, healthy lives and have effectively no risk of sexually transmitting HIV to their HIV-negative partners. With active ART assistance through healthcare workers, the epidemic can be brought down rapidly in the coming years.

Another aspect of HIV awareness is HIV care continuum, which refers to the sequence of steps a person with HIV takes from diagnosis through receiving treatment until his or her viral load is suppressed to undetectable levels.

With 66% of AIDS patients virally suppressed by 2020, there is abundant hope for the world against the disease, at a scale never experienced before. Curbing the spread of the disease from an HIV positive mother to her child is another big step in limiting the disease in the young population. According to the UNIAIDS report, in 2020, 84% of pregnant women with HIV received ART to prevent transmitting HIV to their babies during pregnancy and childbirth and to protect their own health. This is a huge step in helping to stop the spread of the disease in the next generation.

As global authorities continue to come together to collectively combat the deadly virus, the aim remains the same. Creating a new generation of healthy children, and safeguarding HIV positive lives throughout the world, to help them lead a healthier life. Spreading awareness about AIDs is not just about improving the quality of life for patients, but also helping them live a life free of stigma and discrimination. w w w.medgatetoday.com December 2021

53

PRE

UPDATE EVENT

11-13 DEC 2021 AMTZ CAMPUS, VIZAG, INDIA

I

n line with Healthy India Vision 2025, Icexpo Consults Pvt Ltd together with Andhra Pradesh MedTech Zone (AMTZ) are proud to present India International Medical Equipment Expo 2021 co-located at India International Hospital Needs Expo.

This highly anticipated expo on Medical Equipment will be the first of its kind to cover the entire spectrum from Medical Equipment and Devices, Disposables and Consumer Goods, Imaging and Diagnostics, Air Medical Evacuation & HEMS, Healthcare and General Services, IOMT, AI and Data Analytics, Healthcare Infrastructure and Assets, Orthopaedics, Physiotherapy and Rehabilitation as well as Preventative and Post-Diagnostic Treatments.

The three-day tradeshow will also provide delegates and visitors with the opportunity to participate in the conference being held concurrently. Business Delegates can avail the prospect of pre-set B2B meeting with potential clients as well as suppliers. The fraternity of healthcare professionals will also have the prospect of attending CME during the show.

When and Where?

On the occasion of the 90 th birth anniversary of luminary visionary leader Dr A P J Abdul Kalam, IIME 2021 will take place on 11 th December 2021 until 13 th December 2021 at the prestigious Kalam Convention Center on AMTZ Campus in Vizag, Andhra Pradesh.

Major participants to the show include- Medtronic, Transasia Bio-Medicals Ltd, Sahajand Medical Technologies, Trivitron Healthcare, Medika Bazar, Molbio Diagnostics, Schiller Healthcare India, Evonik India, TUV Rheinland, TSI India, Accurex, Allied Medical Ltd etc alongside numerous SMEs startups and incubators who would be the future pillars of Indian Medical device industry.

54 December 2021 w w w. m e d g a te to d a y.co m

DR. JITENDRA SHARMA MD & CEO, AMTZ

Supported By: The Three days of Exhibition and Summit show is supported by industry stakeholders such as Invest India, The Association of Healthcare Providers India(AHPI), Consortium of Accredited Healthcare Organisation (CAHO) The Association of Indian Medical Device Industry (AiMed), Association of Diagnostics Manufacturers India (ADMI), Force BioMedical and the Public Procurement Group.

Parallel Programs: Industry specific Conferences, Plenary Sessions, Procurement workshops, B2B and B2G meetings and Doctors CMEs will run parallel to the exhibition alongside special sessions portraying India- as the Next Investment Frontier in MedTech.

About the co-host : AMTZ: Andhra Pradesh MedTech Zone was conceived to create a world-class manufacturing hub in India and catapult India as a global destination to manufacture MedTech products for one of the world’s biggest markets – India with a clear focus on bringing in innovation and providing easy and affordable access to healthcare products.

Also known as the MedTech capital of India, AMTZ was initiated to be a one-stop solutions for medical technology needs and is the world’s first such facility that allows someone to build a prototype as well as manufacture high-end devices such as CT scanners and MRI machines, all under one roof.

Conceptualised under the aegis of Dr. Jitendra Kumar Sharma,

PRE

EVENT the Founder Director and CEO AMTZ stands tall and keep the tag of World’s largest Medical Device Manufacturing Eco Zone.

About the Organizer : ICEXPO CONSULTS ICEXPO consist of a team of highly skilled professionals having experience of 25+ years in exhibition industry with proven expertise in creating business opportunities through exhibitions, events & conferences for different sectors of the industry by building up and planning B2B and B2C meetings.

ICEXPO brings together different kinds of businesses around the world under one umbrella to discover new opportunities in their industry and be aware of the forecast of the future growth; creating new possibilities to connect with new partners and discover new customers and suppliers. ICEXPO is focused on creating and connecting opportunities for exhibition organizers, exhibitors & visitors at leading exhibitions, conferences, events and trade consulates for delegations to India and worldwide.

Mr. Shareef Rahman, Managing Director of Icexpo Consults Pvt Ltd brings with him over 3 decades of Trade Fair experience and is also Founder, Managing Partner and CEO of the International Expo Consults, one of the Middle East’s leading exhibitions and trade shows organizers since 1994 to date. “ Med Tech is the next sunrise sector for global economy. Rapidly growing at an unprecedented pace, it has the capability and potential to boost patient care, affordable health, tech develop- ment and economic prosperity. Let’s explore this unique opportunity to learn together, grow together and explore collaborative strategies for milestones that we can reach collectively.

SHAREEF RAHMAN

Managing Director Icexpo Consults Pvt Ltd

The ICEXPO- Medical Devices will be a historic and unique gateway to enhance our synergies to boost care, capacity and creativity in Med Tech” The ICEXPO- Medical Devices will be a historic and unique gateway to enhance our synergies to boost care, capacity and creativity in Med Tech”— Dr. Jitendra Sharma, Founder CEO & Managing Director, Andhra Pradesh Medtech Zone Ltd (AMTZ) “IIME/IIHN 2021 would be the turning point for the Indian Healthcare industry and will be showcasing the technological advancement in the medical device sector thus creating a platform for the manufactures and user industry to network together. We Team Icexpo invites you all healthcare professional to be personally present at this unique event. “ CEO & Managing Director, Icexpo Consults Pvt Ltd.

55

PRE

UPDATE EVENT

HAEMOCON 2022 – INDIA'S MOST COMPREHENSIVE DIAGNOSTIC SUMMIT, HAEMATOLOGY CONFERENCE, AND AWARDS CEREMONY WILL BE HELD ON 21ST JANUARY 2022 IN NEW DELHI

H

aemocon 2022 aims to bridge the gap between technology and endusers. Haemocon 2022 will connect the participants with other healthcare industry peers and bring them face-to-face with the entire spectrum of haematology, pathology, IVD, and diagnostic. Haemocon 2022 will catalyse new relationships for business and professional growth and provide a platform for product launch, product showcasing, and knowledge exchange. New technologies transforming our world are at the event's focal point, including innovative, efficient state-of-theart medical devices, cost-effective disposables, testing developments, and equipment advancements.

The Haematology Market Haematology is the third-largest segment in the Indian IVD market, constituting 18–20 percent of the total IVD market share. The Indian haematology instruments and reagents market in 2020 stood at around Rs 850 crores. Reagents constituted 62 percent of the market at Rs 530 crores, and instruments at around 320 crores. As per a Markets and Markets study, the global haematology analysers and reagents market size will grow at 6.9% to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020.

The Opportunities & Challenges The haematology segment is growing at a swift pace, and there are multifaceted opportunities. Over the past decades, haematology analysers have experienced significant technical advancements, featuring low turnaround time, enhanced

56 December 2021 w w w. m e d g a te to d a y.co m

Jatin Mahajan

organising chairman Haemocon 2022

precision, and accuracy. Consequently, the challenges associated with manual methods like immature cells, reliability of results, distribution error, and statistical error make way for precise, safe, and dependable automated haematology systems.

There are various challenges in this dynamic and ever-changing landscape. India has about 1.1 lakh laboratories, but their concentrations are primarily in urban areas.

The rural population constitutes 70% of our total population but only about 36% of the laboratories. This 36 % or approximately 40,000 laboratories are situated in tier-II and tier-III cities, covering the rural and semi-urban population with limited access to most IVD technologies. Therefore, the benefits of IVD technologies remain underserved to the patients in these rural areas. The introduction of highly compact 3-part and 5-part haematology systems has been a significant development. These compact systems are well suited for rural India and will bring in changes in the IVD industry. These technological advancements will decrease TAT (turn-around-time) and bring the POC (point-of-care) closer to the rural folks.

Why is the Event Significant?

Haematology is a fast-paced, dynamic industry with regular product and

Dr. Neeraj Jain Co - Chair Haemocon 2022

technological developments. Technology is changing the traditional understanding of laboratory haematology workflow and standards, broadening capabilities beyond conventional methodologies.

Diagnostics form the first line of defense against diseases, and yet, there has been no platform that offers the opportunity to update oneself regarding the latest developments in the sector. Haemocon aims to change this. The Conference aims to explore new technologies and innovations in the industry, share insights with industry disruptors and thoughtleaders, understand the sector's future, and collectively work towards growth and service to humanity.

About Haemocon 2022 Leading luminaries from the Haematology industry are organising Haemocon 2022. Mr. Jatin Mahajan (MD, J Mitra & Co) is the Chairman of the organising committee, and Dr. Neeraj Jain (Pathologist & Founder President – MELAP) is the co-Chairman. In addition, the advisory panel comprises Smt Rama Venugopal and Mr. Surajit Bit. Haemocon 2022 is powered by Medical Fair India and has Invest India and Nasscom as strategic partners. Advance Media Group is organising the event.

PRODUCT LINE

TRANSITION FROM ANALOGUE TO DIGITAL IMAGING FOR IMAGE GUIDED SURGERIES

C

-Arms and Cath-Labs are sophisticated medical imaging equipment that find extensive use in various operating room settings for image guided surgeries. CathLabs are generally used for Cardio-vascular procedures like angiography and angioplasty as well as complex neurosurgeries. Mobile C-Arms finds usage in predominantly Orthopedic, Urology, Spine and General Surgeries.

C-Arms and Cath-Labs are based on X-ray technology and provide high-resolution X-ray images in real time during the surgery to allow medical professionals precisely carry out complex surgical procedures in a minimally invasive manner. This makes the surgical procedure less painful for the patient and leads to a much quicker recovery.

The C-Arm gets its name from the C shaped arm that holds an X-ray tube at one end and an Image Intensifier or a Flat Panel Detector at the other end. The patient is positioned between the X-ray tube and the Image Intensifier / Flat Panel Detector. The Arm can be moved horizontally, vertically and can be rotated around the swivel axis to properly position the patient in the X-ray field and acquire the desired images. The console of C-Arm would generally house the high voltage power electronics needed for the X-ray tube, control electronics for managing the C-Arm movement and embedded computer systems for image acquisition and processing.

C-Arm technology has evolved continuously since its introduction in 1955; and most recent technology trend is migration from Image Intensifier based Analogue technology to Flat Panel Detector based Digital Technology. In Analogue Image Intensifier C-Arms; the X-ray beam after penetrating the patient’s body hits the Input Phosphor end of the Image Intensifier; the Input Phosphor converts the X-ray to light photons which passes through a vacuum tube with an arrangement of PhotoCathode, Electrostatic Focusing Lens, PhotoAnode finally reaching the Output Phosphor end of the Image Intensifier and forms a visible image of the X-rayed body parts. This image is then captured by a CCD camera and gets transmitted to the display monitors.

58 December 2021 w w w. m e d g a te to d a y.co m

In case of Analogue C-Arms, the image conversion happens in two steps; Step 1 X-ray to Visible Light Image conversion by the Image Intensifier; Step 2 Capture of Visible Light Image by CCD camera and further processing using Analogue means. Due to the curved surface of the Image Intensifier tube the accuracy of the image is diminished near the edges leading to distortion. Furthermore due to multiple steps and electron optics involved in the imaging chain; the field of vision is reduced with every step of magnification.

Flat Panel Digital Technology directly converts the X-Ray to an electrical charge which gets digitized in the detectors readout matrix.

An Image Processing software converts the digital input from the detector to a digital image with a plethora of image processing options leading to high contrast and high resolution images that help visualize very minute anatomical structures. Digital C-Arms provide distortion free accurate images edge to edge of the entire viewing field.

PRODUCT LINE

Trivitron Healthcare is at the forefront of innovation in Medical Imaging using Digital Technology, having launched Digital Radiography, Digital Mammography and now being the leader in Digital C-Arms.

Image Intensifier Limited Field of View Distortion is visible

Flat Panel Edge-to-Edge - Extended Field of View

Images free of Distortion

Trivitron Healthcare offers a wide range of Digital C-Arm options; the Infinity series with 3.5 KW stationary anode and the Elite series with 5 KW rotating anode X-ray Monoblocs.

Trivitron Healthcare C-Arms feature advanced software with Digital Subtraction Angiography, Roadmapping features along with dual panel or wide screen single panel display options.

MR. SATYAKI BANERJEE

CEO, Medical Imaging, Trivitron Healthcare

w w w.medgatetoday.com December 2021

59

SPIROMETER SP10BT

Almedequipment.com almedequip@gmail.com 9322510636, 9768941838

CONVERT ANY OT INTO COVID–19 FREE OT WITHIN

72 HOURS

Almed equipments introduce a exciting offer for complete package of modular operation system which includes our best products:-ductless laminar air flow system, ductless air handling unit with display, vinyl flooring, hermetically sealed swing door.

BENEFITS OF DUCTLESS • 8 TR Outdoor Unit sufficient to give cooling in OT.vs the 11tr compressor in ducted system • 0.180 kW blower to give air velocity 90-120 FPM flow at grill/diffuser level.vs 3-5 KW in ducted System DETAILS OF DUCTLESS LAMINAR AIR FLOW SYSTEM INCLUDES

Has a burning unit attached to it that generates temperature between 70 to 85 degree Celsius that is used to deactivate the biological burden before releasing it to the surrounding atmosphere.

Feature Of O3 GEN – The Magical Air Disinfectant without any chemicals :- O3 Gen Kills all types of bacteria , Fungus , virus molds and reduces the biological burden upto 93% with 2.5 ppm concentration within 30 minutes. ozone having half life just 10 minutes and its biproduct is oxygen which is very safe to use in unoccupied operation theaters.

DETAILS OF DUCTLESS AIR HANDLING UNIT WITH DISPLAY INCLUDES

Almed Equipment has introduced a new type patented and exclusive Ductless Air handling Unit which has Ultra HEPA (High-efficiency particulate air) filter with 0.1 micron filtrate.

DETAILS OF VINYL FLOORING It is an anti static flooring with 2mm thickness. mechanical stress and dynamic loads.

It provides resistance to

DETAILS OF HERMETICALLY SEALED SWING DOOR

SS handle for opening and push plate, Lock and Auto bottom seal make airtight.

Hand and Foot sensor Operated Size 5’X7’

Price 2999 tax inclusive Power consumption 2 watt Cover area 150 to 180 sq. Ft Improve immunity Power consumption 2 watt No filteration No maintenance Improve immunity Increase metabolism 100% safe Good for health Best for room indicator - red led ONE YEAR REPLACEMENT WARRANTY

Preventive Healthcare Clothing Unique Products from HealtHive.

SPECIALISES IN Scrubs Lab Coats Surgical Gowns Coveralls PPE Kits Masks Uniforms Aprons Sheet sets Curtains and more...

Shop at: https://healthive.trigger.in enquiry@trigger.in

04254-235537 w w w.medgatetoday.com December 2021

Viroguard Loop

Viroguard Stretch Band

Viroguard Tie

To buy Genuine Magnum Masks scan following codes Only for Doctors

Address

December 2021 w w w. m e d g a te to d a y.co m

To Buy from Flipkart

REVIEW

Manufacturers & Exporters

of Medical Disposables & Kits

‘‘Innovation To Excel Quality Safety & Perfomance ’’

Available In :

PPSB / LAMINATED / SMMS / SSMMS WITH TAPING / WITH OUT TAPING

PPSB / LAMINATED / SMMS / SSMMS

FOR MORE DETAILS :

www.acuron.in Gala No. 101 & 103, A16, Pritesh Complex, Dapoda Rood, Val Village, Bhiwandi - 421 302.

December 2021 w w w. m e d g a te to d a y.co m

Mitesh Ghia +91 9930999336 / Jayesh Sheth +91 9820043274

sales@acuron.in

J. MITRA OFFERS COMPLETE RANGE OF

COVID-19

ELISA TEST KITS

COVID 19 Ag MICROLISA

COVID 19 NEUTRALIZING ANTIBODY MICROLISA

BASED ON SANDWICH ELISA PRINCIPLE

BASED ON BLOCKING ELISA PRINCIPLE

INCUBATION TIME: 105 MINUTES

INCUBATION TIME: 75 MINUTES

SENSITIVITY: 100% & SPECIFICITY: 100%

SENSITIVITY: 95.89% & SPECIFICITY: 100%

COVID KAWACH IgG MICROLISA

COVID 19 (IgM + IgG + IgA) MICROLISA BASED ON DOUBLE ANTIGEN SANDWICH ELISA PRINCIPLE

BASED ON INDIRECT ELISA PRINCIPLE INCUBATION TIME: 130 MINUTES

INCUBATION TIME: 90 MINUTES

SENSITIVITY: 96.33% & SPECIFICITY: 100%

SENSITIVITY: 94.04% & SPECIFICITY: 100%

ELISA READER & ELISA WASHER ALSO AVAILABLE ELISA Reader

ELISA Reader

ER-180

ER-181s

ELISA Washer

EW-181s

J. Mitra & Co. Pvt. Ltd. Since 1969

• Rapid Test Kits • Elisa Test Kits • Confirmatory Tests • Blood Grouping Sera • Fluorescence Immunoassay Test Kits E-mail: jmitra@jmitra.co.in |Tel.: +91-11-471-30-300 | www.jmitra.co.in

REVIEW HEALTHCARE

SURGICAL K IT

SOLUTIONS & EXPERIENCES IN INFECTION PREVENTION

GICAL DRAPE R S SU

Thank You For 20 Years of Support

STERILISATION WRAPS & STERILE FIELDS

MANUFACTURING UNDER CLEAN ROOM CONDITIONS as per ISO 14644

VALIDATED STERLIZATION PROCESS & SEALING PROCESS as per ISO 11135 & ISO 11607

CERTIFIED QUALITY MANAGEMENT SYSTEM FOR MEDICAL DEVICES as per ISO 13485 : 2016 by TUV Rheinland

EN ISO 13485: 2016 + AC:2016 QUALITY MANAGEMENT SYSTEM www.tuv.com

FOR MEDICAL DEVICES

+91-9866754202

SINGLE USE

CUSTOM - ENGINEERED SURGERY SPECIFIC STERILE PROCEDURE KITS

+91-9903686749

Distrbution Partners - contact : +919844086659, +919845040165

December 2021 w w w. m e d g a te to d a y.co m